Page last updated: 2024-08-26

artenimol and Malaria

artenimol has been researched along with Malaria in 214 studies

Research

Studies (214)

TimeframeStudies, this research(%)All Research%
pre-19905 (2.34)18.7374
1990's7 (3.27)18.2507
2000's27 (12.62)29.6817
2010's106 (49.53)24.3611
2020's69 (32.24)2.80

Authors

AuthorsStudies
Blank, BR; Gut, J; Renslo, AR; Rosenthal, PJ1
Basarab, G; Cabrera, DG; Chibale, K; Eyermann, CJ; Horatscheck, A; Wilson, CR1
Bane, CE; Bayles, BR; Black, C; Butler, K; Caridha, D; Ceja, FG; Cooper, RA; Dodean, RA; Gaona, H; Gaynor-Ohnstad, L; Kancharla, P; Kelly, JX; Kreishman-Deitrick, M; Leed, SE; Li, Q; Li, Y; Lin, H; Luong, TL; Marcsisin, S; Melendez, V; Mu, J; Nolan, C; Olmeda, R; Potter, B; Pou, S; Pybus, B; Rasmussen, SA; Read, L; Reynolds, KA; Riscoe, MK; Roncal, N; Rosenthal, PJ; Sciotti, RJ; Smilkstein, MJ; Sousa, J; Tumwebaze, PK; Vesely, B; Vuong, C; Xie, L; Zeng, Q; Zhang, J; Zhang, P1
Aratikatla, EK; Asad, M; Bhattacharya, AK; Datta, G; Kalamuddin, M; Malhotra, P; Mohmmed, A; Rana, KC; Sundararaman, S1
Asakawa, AH; Brockmeyer, F; Casandra, D; Huang, L; Kyle, DE; LaCrue, AN; Maher, SP; Maignan, JR; Manetsch, R; Mashkouri, S; Monastyrskyi, A; Padin-Irizarry, V; Parvatkar, PT; Sakhno, YI; Zhao, Y1
Guan, W; Li, G; Su, W; Wang, Y; Yang, J; Yao, H; Zhang, S1
Klayman, DL; Lee, M; Lin, AJ1
Brossi, A; Buchs, P; Dominguez Gerpe, L; Flippen-Anderson, JL; Luo, XD; Milhous, W; Peters, W; Venugopalan, B; Yeh, HJ1
Ager, AL; Andersen, SL; Dong, Y; Edwards, G; Fu, H; Gerena, L; Holme, AD; Kyle, DE; McLean, WG; Milhous, WK; Miller, RE; Vennerstrom, JL; Walters, SM; Wesche, DL; Wood, JK1
Bishop, LP; Hindley, S; Maggs, JL; Miller, A; O'Neill, PM; Park, BK; Posner, GH; Roberts, SM; Scheinmann, F; Stachulski, AV; Ward, SA1
Brun, R; Charman, SA; Charman, WN; Chiu, FC; Chollet, J; Dong, Y; Dorn, A; Karle, JM; Matile, H; Santo Tomas, J; Scheurer, C; Scorneaux, B; Snyder, C; Tang, Y; Urwyler, H; Vennerstrom, JL; Wang, X; Wittlin, S1
Batty, KT; Law, AS; Moore, BR; Stirling, V1
Andrzejewski, C; Batty, KT; Ilett, KF; Jago, JD; Moore, BR; Page-Sharp, M1
Adrián, F; Anderson, P; Brinker, A; Caldwell, JS; Chatterjee, A; Gray, NS; Henson, K; Janes, J; Kato, N; Kuhen, K; Matzen, JT; McNamara, C; Nagle, A; Nam, TG; Plouffe, D; Schultz, PG; Trager, R; Winzeler, EA; Yan, SF; Zhou, Y1
Aminake, MN; Chibale, K; de Kock, C; Grobler, A; Hans, R; Kirschner, M; Kumar, V; Mahajan, A; Pradel, G; Rethwilm, A; Smith, PJ; Taylor, D; Wiesner, L1
Biamonte, MA; Le Roch, KG; Wanner, J1
Bathurst, I; Burrows, JN; Charman, SA; Cross, RM; Flanigan, DL; Fronczek, FR; Guida, WC; Kyle, DE; LaCrue, AN; Maignan, JR; Manetsch, R; Monastyrskyi, A; Mutka, TS; Sáenz, FE; Shackleford, DM; White, KL; Wojtas, L1
Battistuzzi, G; Giannini, G; Vignola, D1
Baguma, E; Boyce, RM; Brown-Marusiak, A; Goel, V; Hollingsworth, BD; Juliano, JJ; Muhindo, R; Mulogo, EM; Ntaro, M; Reyes, R; Siedner, MJ; Staedke, SG; Xu, E1
Dimessa, LB; El Gaaloul, M; Esen, M; Garcia-Otero, L; González, R; Lagler, H; Lell, B; Menendez, C; Mischlinger, J; Mombo-Ngoma, G; Nhampossa, T; Piqueras, M; Pons-Duran, C; Ramharter, M; Sanz, S; Saute, F; Sevene, E; Tchouatieu, AM; Zoleko Manego, R1
Aweeka, F; Clark, TD; Dorsey, G; Hughes, E; Jagannathan, P; Kajubi, R; Kakuru, A; Kamya, MR; Ochieng, T; Rosenthal, PJ; Savic, RM; Wallender, E1
Achan, J; Bousema, T; Bradley, J; Broekhuizen, H; Ceesay, F; Conteh, B; D'Alessandro, U; Dabira, ED; Drakeley, C; Kandeh, B; Lindsay, SW; Mohammed, N; Ndiath, MO; Peeters Grietens, K; Slater, H; Smit, MR; Soumare, HM1
Cui, Z; Jiang, T; Li, C; Li, L; Li, S; Ma, J; Qin, T; Shi, H; Tang, T; Wang, H; Xu, W; Zhou, H1
Baraka, V; Kamugisha, E; Kapesa, A; Kidenya, B; Konje, E; Marwa, K; Mukonzo, J; Swedberg, G1
Allen, E; Banda, CG; Barnes, KI; Chirwa, M; Kapulula, M; Maartens, G; Madanitsa, M; Munharo, S; Muyaya, S; Mwapasa, V; Nkosi, D; Phiri, KS; Ter Kuile, FO; Wiesner, L; Workman, L1
Grundmann, O; Hernandez Maldonado, J1
Attaher, O; Bousema, T; Bradley, J; Diallo, M; Dicko, A; Dicko, OM; Drakeley, C; Issiaka, D; Keita, S; Lanke, K; Maguiraga, SO; Mahamar, A; McCall, MBB; Niambele, SM; Sacko, A; Samake, S; Sanogo, K; Sinaba, Y; Smit, MJ; Stone, W; Ter Heine, R; Traore, SF1
Siahaan, L1
Bruschi, F; Fabiani, S; L'Episcopia, M; Mangano, V; Motta, V; Severini, C; Sparavelli, R; Verdenelli, S1
Buff, AM; Chebore, W; Desai, M; Kariuki, S; Otieno, K; Owidhi, M; Samuels, AM; Westercamp, N1
Clapp, S; Freedman, B; Green, CL; Kirui, JK; Korwa, S; Njuguna, FM; O'Meara, WP; Taylor, SM; Wu, A1
Apayi, C; Bangirana, P; Conroy, AL; Dorsey, GM; Georgieff, MK; Havlir, D; Jang, JH; John, CC; Kakuru, A; Kamya, MR; Muhindo, MK; Opoka, RO; Semrud-Clikeman, M1
Cahyaningsih, U; Maring, AJ; Nugraha, AB; Sa'diah, S; Sari, RK; Syafii, W1
Allen, E; Banda, CG; Barnes, KI; Chirwa, M; Kapulula, M; Maartens, G; Madanitsa, M; Munharo, S; Muyaya, S; Mwapasa, V; Nkosi, D; Phiri, KS; Tarning, J; Ter Kuile, FO; Workman, L1
Bousema, T; Bradley, J; Camara, MM; Ceesay, S; Conteh, B; D'Alessandro, U; Dabira, ED; Drakeley, C; Erhart, A; Gaye, PM; Jadama, L; Jawara, EA; Kanteh, S; Lindsay, SW; Mohammed, N; Ndiath, MO; Njie, AK; Ooko, M; Sanneh, F; Soumare, HM1
Assefa, A; Bekele, W; Chernet, M; Commons, RJ; Etana, K; Gidey, B; Girma, S; Gubae, K; Haile, M; Hailgiorgis, H; Mohammed, H; Sime, H; Solomon, H; Tasew, G; Tollera, G1
Arora, P; Malhotra, P; Mohmmed, A; Mukhtar, O; Narwal, M; Thakur, V1
Baraka, V; Chacky, F; Challe, DP; Chiduo, M; David, A; Francis, F; Gesase, S; Kamugisha, M; Lazaro, S; Liheluka, E; Lusasi, A; Lusingu, JPA; Makenga, G; Mandara, C; Mhina, A; Minja, DTR; Mmbando, BP; Mohamed, A; Molteni, F; Mtove, G; Nkayamba, A; Segeja, M; Seth, MD; Thawer, S; Van Geertruyden, JP1
Abuaku, B; Amoako, EO; Asamoah, A; Boateng, P; Duah-Quashie, NO; Koram, KA; Malm, KL; Matrevi, SA; Owusu-Antwi, F; Peprah, NY; Quashie, N1
Amoah, B; Bukenya, F; Colborn, K; Echodu, DC; Eganyu, T; Elliott, RC; Giorgi, E; Gonahasa, S; Kilama, M; Mulebeke, R; Nankabirwa, J; Odude, W; Omoding, O; Opigo, J; Powell, SE; Roskosky, M; Wanzira, H; Yeka, A1
Adjei, GO; Ahorhorlu, SY; Alifrangis, M; Duah-Quashie, NO; Dzudzor, B; Hansson, H; Jensen, RW; Kudzi, W; Nartey, ET; Quashie, NB; Wang, CW; Zoiku, F1
Arinaitwe, E; Kamya, MR; Kiyimba, A; Nankabirwa, J; Obondo, SJ; Ocan, M; Okek, EJ; Ssewanyana, I1
Akinola, O; Amusan, AI; Ategbero, E; Gbotosho, GO1
Ali, AM; Dorsey, G; Hughes, E; Savic, RM; Wallender, E1
Akun, P; Galileya, LT; Idro, R; Kalibbala, D; Nambatya, W; Nkosi-Gondwe, T; Opoka, R; Phiri, K; Robberstad, B; Rujumba, J; Ssenkusu, J; TerKuile, F1
Akala, HM; Amwoma, JG; Andagalu, BM; Chemwor, GC; Cheruiyot, AC; Egbo, TE; Garges, EC; Juma, DW; Juma, JA; Kamau, E; Mwakio, EW; Ogutu, BR; Okoth, RO; Onyango, IA; Opot, BH; Roth, AL; Wakoli, DM; Watson, OJ; Yedah, RA1
Aina, O; Awolola, ST; Babatunde, S; David, AN; Ekama, SO; Happi, CT; Ijezie, SN; Mohammed, AB; Mokuolu, O; Musa, AZ; Ogbulafor, N; Oguche, S; Okafor, H; Olukosi, AY; Ozor, L; Salako, BL; Uhomoibhi, PE; Wammanda, R1
Chepngetich, J; Gachie, B; Gathirwa, J; Kiboi, D; Kimani, F; Magoma, G; Muriithi, B; Mwitari, P; Onchieku, N; Thiong'o, K1
Baird, JK; Berni, A; Budiman, W; Cedar, E; Chand, K; Crenna-Darusallam, C; Duparc, S; Ekawati, LL; Elyazar, I; Fernando, D; Fletcher, K; Goyal, N; Green, JA; Instiaty, I; Jones, S; Kleim, JP; Lardo, S; Martin, A; Noviyanti, R; Prasetya, CB; Rolfe, K; Santy, YW; Satyagraha, AW; Sharma, H; Soebandrio, A; Subekti, D; Sutanto, I; Tan, LK; Taylor, M1
Arcelia, F; Pasaribu, AP; Yanni, GN1
Asahi, H; Inoue, SI; Kobayashi, F; Niikura, M; Sendo, F; Wada, A1
Bradley, J; D'Alessandro, U; Dit Massire Soumare, H; Drakeley, C; Hutchins, H; Jones, RT; Last, AR; Logan, JG; Mabey, D; Martins, C; Nante, EJ; Ndiath, MO; Pretorius, E; Rodrigues, A; Slater, H; Teixeira da Silva, E; Vasileva, H1
Eisenberg, SL; Krieger, AE1
Baraka, V; Francis, F; Geertruyden, JV; Gesase, S; Kyaruzi, E; Lusingu, JPA; Madebe, R; Makenga, G; Minja, DTR; Mtove, G; Nakato, S1
Asih, PBS; Basri, HH; Bustos, MDG; Charunwatthana, P; Dewayanti, FK; Dondorp, AM; Imwong, M; Permana, DH; Prameswari, HD; Rahmasari, FV; Risandi, R; Rozi, IE; Syafruddin, D; Syahrani, L; Wangsamuda, S1
D'Alessandro, U; Dabira, ED; Diakite, H; Djimde, M; Dorlo, TP; Erhart, A; González, R; Kabore, B; Kayentao, K; Keita, M; Macuacua, S; Menendez, C; Mens, P; Muhindo, HM; Piqueras, M; Sagara, I; Schallig, H; Sevene, E; Tinto, H; Traore, M; Tshiongo, JK; Vala, A1
Arama, C; Beavogui, AH; Dicko, A; Djimde, A; Djimde, M; Fofana, B; Kayentao, K; Mens, PF; Ouedraogo, JB; Sagara, I; Schallig, HD; Sirima, SB; Tshiongo, JK1
Abebe, A; Ahmedin, M; Atim, MG; Embaye, SM; Kahabuka, M; Kazembe, D; Manyazewal, T; Mesfin, T; Muthoka, EN; Namuganza, S; Usmael, K1
Bukenya, F; Collborn, K; Echodu, D; Eganyu, T; Elliot, R; Mulebeke, R; Van Geertruyden, JP; Wanzira, H; Yeka, A1
Cui, Z; Guo, S; Jiang, T; Li, C; Li, L; Ma, J; Tang, T; Wang, H; Xu, W; Zhou, Y1
Bienvenu, AL; Bonnot, G; Kouakou, YI; Lavoignat, A; Leboucher, G; Picot, S; Tod, M1
Chandler, CIR; Dorsey, G; Drakeley, C; Gonahasa, S; Kamya, MR; Kigozi, SP; Maiteki-Sebuguzi, C; Okiring, J; Rehman, AM; Staedke, SG1
Davidson, SA; Day, NPJ; Dondorp, A; Hanboonkunupakarn, B; Hoglund, RM; Jittamala, P; Kobylinski, KC; Mukaka, M; Pantuwatana, K; Phasomkusolsil, S; Pukrittayakamee, S; Tarning, J; van der Pluijm, RW; White, NJ; Winterberg, M1
Ahmad, RA; Kenangalem, E; Laksono, IS; Lampah, DA; Murhandarwati, EEH; Poespoprodjo, JR; Sikora, SA; Sugiarto, P1
Aweeka, F; Huang, L; Hughes, E; Kajubi, R; Mwebaza, N; Mwima, MW; Nguyen, V; Nyunt, MM; Orukan, F; Parikh, S1
Aljayyoussi, G; Alout, H; Bousema, T; Burrows, J; Chaccour, C; D'Alessandro, U; Foy, BD; Ghani, AC; Hellewell, J; Kobylinski, K; Slater, HC; Smit, MR; Ter Kuile, FO; Walker, PGT; Watson, OJ1
Aide, P; Alonso, PL; Bassat, Q; Chidimatembue, A; Cisteró, P; Galatas, B; Gupta, H; Huijben, S; Matambisso, G; Mayor, A; Ménard, D; Nhamussua, L; Rabinovich, NR; Ringwald, P; Saúte, F; Simone, W1
Desai, M; Dorsey, G; Fernandes, S; Gutman, J; Hanson, K; Kakuru, A; Kamya, MR; Kariuki, S; Ter Kuile, FO; Were, V1
Alemayehu, BH; Amaratunga, C; Anvikar, AR; Ashley, EA; Asih, PBS; Carrara, VI; Commons, RJ; D'Alessandro, U; Davis, TME; Dondorp, AM; Douglas, NM; Edstein, MD; Fairhurst, RM; Ferreira, MU; Guerin, PJ; Hossain, MS; Hwang, J; Janssens, B; Karunajeewa, H; Kiechel, JR; Ladeia-Andrade, S; Laman, M; Lon, C; Mayxay, M; McGready, R; Moore, BR; Mueller, I; Newton, PN; Noedl, H; Nosten, F; Phyo, AP; Poespoprodjo, JR; Price, RN; Saunders, DL; Simpson, JA; Smithuis, F; Spring, MD; Stepniewska, K; Suon, S; Suputtamongkol, Y; Syafruddin, D; Thriemer, K; Thuy-Nhien, NT; Tran, HT; Valecha, N; Van Herp, M; Van Vugt, M; White, NJ1
Ahmed, R; Ansariadi, A; Bonsapia, I; Burdam, FH; Hill, J; Khairallah, C; Paintain, L; Rini Poespoprodjo, J; Syafruddin, D; Ter Kuile, FO; Umbu Reku Landuwulang, C; Webster, J1
Bruce, J; Desai, M; Hill, J; Kariuki, S; Oluoch, S; Ouma, P; Webster, J1
Boele van Hensbroek, M; Desai, MR; Dhabangi, A; Idro, R; John, CC; Kariuki, S; Kuya, NA; Kwambai, TK; Onyango, ED; Opoka, R; Otieno, K; Phiri, KS; Robberstad, B; Samuels, AM; Ter Kuile, FO; Wang, D; Watson, V1
Achan, J; D'Alessandro, U; de Vries, D; Grietens, KP; Gryseels, C; Jaiteh, F; Masunaga, Y; Okebe, J; Ribera, JM1
Hafid, AF; Ilmi, H; Prasetyo, B; Tumewu, L; Widyawaruyanti, A1
Akello, F; Amongi, S; Amongin, R; Cose, S; Elliott, AM; Kabuubi, PN; Kiwanuka, S; Kiwudhu, F; Kizindo, R; Mutebe, A; Nakazibwe, E; Nassuuna, J; Natukunda, A; Nkurunungi, G; Nsubuga, D; Oduru, G; Onen, C; Sewankambo, M; Staedke, SG; Webb, E; Zirimenya, L1
Deng, C; Liang, Y; Lu, C; Song, J; Tan, B; Wang, Q; Wu, W; Xu, Q; Zhang, H; Zhou, C1
Ball, L; Bensman, TJ; Chilukuri, DM; Colangelo, PM; Earp, JC; Kitabi, E; O'Shaughnessy, E; Reynolds, KS; Smith, H; Yasinskaya, Y1
Hughes, E; Jagannathan, P; Mohamed Ali, A; Savic, RM; Wallender, E1
Aklillu, E; Kamuhabwa, AAR; Minzi, O; Mlugu, EM1
Bancone, G; Carrara, VI; Chu, C; Duanguppama, J; Gilder, ME; Haohankhunnatham, W; Imwong, M; Konghahong, K; Lee, SJ; McGready, R; Min, AM; Nosten, F; Paw, MK; Phyo, AP; Pimanpanarak, M; Proux, S; Saito, M; Singhasivanon, P; Tun, NW; Turner, C; Viladpai-Nguen, J; White, NJ1
Kasai, S; Kawamura, K; Kume, A; Suzuki, H; Umemiya-Shirafuji, R1
Baltzell, K; Benjamin-Chung, J; Bhangu, K; Dlamini, B; Dlamini, N; Dufour, MK; Gosling, R; Greenhouse, B; Helb, D; Hsiang, MS; Kalungero, M; Kunene, S; Malambe, C; Maphalala, G; Mngadi, N; Nhlabathi, N; Ntshalintshali, N; Pindolia, D; Prach, LM; Tesfa, G; Vilakati, S; Whittemore, B1
Andronescu, LR; Chinkhumba, J; Gutman, JR; Kachepa, W; Kachingwe, M; Laufer, MK; Liang, Y; Mathanga, DP; Peterson, I; Sharma, A1
Chai, L; Guo, W; Li, N; Li, Y; Ren, G; Wang, R; Wang, X; Yang, L; Yang, Q; Yi, B; Zhang, G; Zhang, S1
Esu, EB; Meremikwu, MM; Oringanje, C1
Abega, F; Ayong, L; Berry, A; Gandia, P; Iriart, X; Khim, N; Lanot, T; Mairet-Khedim, M; Menard, S; Morlais, I; Ngou, C; Nsango, S; Otam, L; Roesch, C; Srun, S; Witkowski, B1
Ategeka, J; Charlebois, ED; Clark, TD; Cohan, D; Dorsey, G; Havlir, DV; Jagannathan, P; Kakuru, A; Kamya, MR; Koss, CA; Muehlenbachs, A; Muhindo, M; Nakalembe, M; Natureeba, P; Nzarubara, B; Ochieng, T; Plenty, A; Rizzuto, G; Ruel, T1
Buyze, J; D'Alessandro, U; Hachizovu, S; Kabuya, JB; Kasongo, W; Mulenga, J; Mulenga, M; Mwakazanga, D; Nambozi, M; Van Geertruyden, JP1
Bouhenia, M; Coldiron, ME; Das, D; Elder, G; Grais, RF; Langendorf, C; Lasry, E; Mwanga, J; Nyehangane, D; Okui, P; Salumu, L1
Affara, M; Bei, AK; Deme, AB; Dieye, B; Diongue, K; Gaye, A; Koita, O; Krogstad, DJ; Mbaye, A; Ndiaye, D; Ndiaye, IM; Ndiaye, T; Ndiaye, YD; Nwakanma, D; Sy, M; Sy, N; Volkman, S; Yade, MS1
Achieng, AO; Ghosh, PC; Kempaiah, P; Kumar, P; Perkins, DJ; Rajendran, V; Rathi, B; Rawat, M; Singh, BK1
Bridgford, JL; Chen, MZ; Hatters, DM; Hong, Y; Moily, NS; Pouladi, MA; Radwan, M; Reid, GE; Smith, TA; Song, Z; Tang, BZ; Tilley, L; Wood, RJ; Xu, X1
Aweeka, FT; Jagannathan, P; Kajubi, R1
Srinivas, NR1
Rabinovich, NR1
Chandler, CIR; Dorsey, G; Drakeley, C; Gonahasa, S; Kamya, MR; Kigozi, SP; Lindsay, SW; Maiteki-Sebuguzi, C; Okiring, J; Rehman, AM; Staedke, SG1
Bassat, Q; Millat-Martínez, P1
Brugada, J; Chan, XHS; Mawer, LJ; Tan, JY; White, NJ; Win, YN1
Arsuaga, M; Dinkessa, AW; González, LM; Gray, J; Montero, E; Padial, ES; Puente, S; Sevilla, E; Trigo, E1
Bernigaud, C; Chosidow, O; Do-Pham, G1
Aol, G; Bigogo, GM; Desai, M; Hill, J; Laserson, KF; Phillips-Howard, PA; Taegtmeyer, M; Ter Kuile, F; Young, N1
Blomberg, B; Gondwe, T; Lange, S; Mukaka, M; Phiri, K; Robberstad, B1
Abong'o, BO; Aljayyoussi, G; Bayoh, NM; Bousema, T; Desai, MR; Gimnig, JE; Kariuki, SK; Kwambai, TK; Ochomo, EO; Phillips-Howard, PA; Samuels, AM; Smit, MR; Ter Kuile, FO; Wang, D; Ward, SA; Waterhouse, D1
Cen, YZ; Deng, ZH; Li, XH; Liao, YB; Lin, RX; Liu, MR; Pan, B; Pei, FQ; Ren, WF; Ruan, CW1
Abel, H; Bassat, Q; Ila, R; Karunajeewa, H; Laman, M; Manning, L; Millat-Martínez, P; Mitjà, O; Moore, B; Pulai, K; Robinson, L; Sanz, S1
Guler, JL; Rosenthal, PJ1
Achan, J; Affara, M; Bousema, T; D'Alessandro, U; di Tanna, GL; Dierickx, S; Drakeley, C; Kanuteh, F; Mohammed, NI; Mwesigwa, J; Nwakanma, D; Prom, A; Van Geertruyden, JP; Wathuo, M; Worwui, A1
Desai, M; Dhabangi, A; Idro, R; John, CC; Kariuki, S; Kwambai, TK; Opoka, R; Phiri, K; Robberstad, B; Samuels, AM; Ter Kuile, FO; van Hensbroek, MB; Wang, D1
Attama, A; Chukwuka, R; Obachie, O; Umeyor, CE1
Ali, AS; Ali, SM; Aydin-Schmidt, B; Bennett, A; Björkman, A; Hodzic, L; Islam, A; Jovel, I; Khamis, M; Magnusson, E; Mårtensson, A; Mkali, H; Morris, U; Msellem, MI; Poirot, E; Sachs, MC; Shija, SJ; Tarning, J1
Blomberg, B; Lange, S; Nkosi-Gondwe, T; Phiri, KS; Robberstad, B1
Bangirana, P; Conroy, AL; Dorsey, G; Jagannathan, P; John, CC; Kakuru, A; Kamya, MR; Liechty, EA; Muhindo, MK; Nakalembe, M; Opoka, RO1
Beavogui, AH; Borghini-Fuhrer, I; Djimdé, AA; Duparc, S; Felices, M; Funck-Brentano, C; Khan, Y; Ouedraogo, JB; Ouologuem, N; Sagara, I; Sirima, SB; Soulama, I; Voiriot, P1
Balen, J; Bradley, J; D'Alessandro, U; Grietens, KP; Gryseels, C; Jaiteh, F; Masunaga, Y; Okebe, J; Ribera, JM1
Hakizimana, D; Kabera, M; Kayobotsi, C; Mbituyumuremyi, A; Munyaneza, T; Murindahabi, M; Musanabaganwa, C; Muvunyi, CM; Nisingizwe, MP; Ntagwabira, E; Penkunas, MJ; Umulisa, N; Uwimana, A; Uyizeye, D; Warsame, M1
Laufer, MK1
Chau Ngo, TM; Dinh Huynh, C; Fiori, PL; Giang Phan, TH; Hanh Nguyen, TL; Hoang, H; Low, PS; Marchetti, G; Pantaleo, A; Pau, MC; Schwarzer, E; Ton Nu, PA; Tsamesidis, I; Tuan Tran, A; Turrini, FM1
Esu, E; Meremikwu, M; Oduwole, O; Okusanya, BO; Olaleye, A1
Lardo, S; Liwang, F; Ratih, DM1
Garrido Jareño, M; Otero Reigada, MDC; Peman García, J; Ramírez Cuentas, JH; Roselló Guijarro, M; Urtasun Erburu, A1
Chen, Q; Chen, R; Feng, Y; Jiang, N; Sang, X; Yang, N; Zhang, T; Zhang, Y; Zhao, X1
Cohee, LM; Laufer, MK1
Cano, J; Chico, RM1
Arinaitwe, E; Aweeka, FT; Bigira, V; Creek, DJ; Kakuru, A; Lindegardh, N; McCormack, S; Nosten, F; Parikh, S; Sandison, TG; Tappero, JW; Wanzira, H1
Efferth, T; Eichhorn, T; Schneider, D; Veerappan, A; Zeino, M1
Poll, EM; Ubben, D1
Amuge, P; Brooker, SJ; Dorsey, G; Kamya, MR; Kiwanuka, N; Nankabirwa, JI; Rosenthal, PJ; Staedke, SG; Wandera, B1
Hastings, IM; Hayes, DJ; Hodel, EM; Kay, K; Terlouw, DJ1
Borrmann, S; Pfeil, J; Tozan, Y1
Achan, J; Arinaitwe, E; Charlebois, E; Clark, TD; Dorsey, G; Havlir, D; Ikilezi, G; Kakuru, A; Kamya, MR; Muhindo, MK; Mwangwa, F; Rosenthal, PJ; Ruel, T; Tappero, JW1
Batty, KT; Gibbons, PL; Kirkpatrick, CM; Moore, BR; Patel, K1
Batty, KT; Benjamin, JM; Davis, TM; Ginny, E; Griffin, S; Moore, BR; Mueller, I; Page-Sharp, M; Robinson, LJ; Salman, S; Siba, P1
Auayporn, M; Buathong, N; Cantilena, L; Chann, S; Chour, CM; Haigney, M; Kaewkungwal, J; Kuntawunginn, W; Lanteri, C; Lon, C; Manning, J; Mitprasat, M; Phann, ST; Prom, S; Saunders, D; Se, Y; Sea, D; Siripokasupkul, R; So, M; Soh, E; Somethy, S; Spring, M; Sriwichai, S; Tang, D; Teja-Isavadharm, P; Timmermans, A; Vanachayangkul, P1
Achan, J; Aweeka, FT; Bigira, V; Clark, TD; Dorsey, G; Havlir, DV; Huang, L; Kamya, MR; Kapisi, J; Kinara, S; Muhindo, MK; Mwangwa, F; Osterbauer, B; Rosenthal, PJ1
Mori, AT; Ngalesoni, F; Norheim, OF; Robberstad, B1
Bhardwaj, TR; Kumar, S; Murthy, RS; Sharma, R; Singh, RK1
Agnamey, P; Degrouas, C; Jonet, A; Mullié, C; Pascual, A; Sonnet, P; Taudon, N1
Achan, J; Aweeka, FT; Bigira, V; Clark, TD; Dorsey, G; Havlir, DV; Huang, L; Jagannathan, P; Kakuru, A; Kamya, MR; Kapisi, J; Kinara, S; Muhindo, MK; Mwangwa, F; Rosenthal, PJ1
Claeys, Y; D'Alessandro, U; De Crop, M; Halidou, T; Kalanda, G; Menten, J; Mulenga, M; Mutabingwa, T; Mwakazanga, D; Mwapasa, V; Nambozi, M; Phiri, LK; Ravinetto, R; Schurmans, C; Tagbor, H; Thriemer, K; Traore, M; Valea, I; Van Geertruyden, JP1
Ewing, VL; Kapinda, A; Lalloo, DG; Pace, C; Richards, E; Terlouw, DJ; Tolhurst, R1
Arinaitwe, E; Aweeka, FT; Bigira, V; Creek, DJ; Kakuru, A; Lindegardh, N; McCormack, SA; Nosten, F; Parikh, S; Sambol, NC; Tappero, JW; Tarning, J; Wanzira, H; Yan, L1
Bhardwaj, TR; Kumar, S; Murthy, RS; Singh, RK1
Day, NP; Hanpithakpon, W; Hlaing, N; Kloprogge, F; McGready, R; Nosten, F; Phyo, AP; Rijken, MJ; Tarning, J; Than, HH; White, NJ; Zin, NT1
Abdulla, S; Adjei, A; Adjuik, M; Akparibo, R; Baiden, R; Binka, F; Compaoré, G; Gyapong, M; Halidou, T; Macete, E; Mulokozi, A; Oduro, A; Ogutu, B; Osei, I; Owusu-Agyei, S; Sevene, E; Sie, A; Smith, P; Upunda, GL; Valea, I; Yawson, A1
Compaore, YD; Greenwood, B; Milligan, P; Nosten, F; Ouedraogo, JB; Rosenthal, PJ; Some, AF; Sutherland, C; Tarning, J; Zongo, I1
Anstey, NM; Fobia, W; Kenangalem, E; Lampah, DA; Poespoprodjo, JR; Price, RN; Sugiarto, P; Tjitra, E1
Bennett, A; Chalwe, V; Eisele, TP; Finn, T; Hamainza, B; Kamuliwo, M; Keating, J; Miller, JM; Moonga, H; Silumbe, K; Steketee, RW; Yukich, J1
Hagihara, Y; Herbas, MS; Ishida, N; Kume, A; Shichiri, M; Suzuki, H; Yoshida, Y1
Aweeka, F; Bigira, V; Dorsey, G; Huang, L; Jagannathan, P; Kakuru, MM; Kamya, MR; Kapisi, J; Savic, R; Sundell, K1
Desai, M; Gutman, J; Juma, E; Kariuki, S; Katana, A; L'lanziva, A; Laserson, K; Otieno, K; Ouma, P; ter Kuile, FO; Were, V; Williamson, J1
Mori, AT; Norheim, OF; Robberstad, B1
Acheampong, PR; Antwi, GD; Bart Plange, C; Cairns, M; Chandramohan, D; Tagbor, H1
Gathirwa, JW; Kalombo, L; Mahanga, GM; Melariri, P; Ogutu, B; Oloo, F; Omwoyo, WN; Swai, H1
Angov, E; Auayapon, M; Chaisatit, C; Chann, S; Chaorattanakawee, S; Dutta, S; Gosi, P; Limsalakpeth, A; Lon, C; Meng Chour, C; Pichyangkul, S; Prom, S; Saunders, DL; Spring, MD; Srichairatanakul, U; Sriwichai, S; Walsh, DS; Yongvanichit, K1
Abdulla, S; Adjei, A; Adjuik, M; Amu, A; Asante, KP; Baiden, R; Binka, F; Compaore, G; Gyapong, M; Halidou, T; Kukula, V; Macete, E; Mulokozi, A; Nagai, RA; Narh-Bana, S; Oduro, A; Ogutu, B; Osei, I; Owusu-Agyei, S; Sevene, E; Sie, A; Valea, I1
Allen, DR; Awino, N; Desai, M; Kariuki, S; Ouma, P; Samuels, A; Shuford, K; Were, F1
Bannister-Tyrell, M; D'Alessandro, U; Dierickx, S; Gerrets, R; Grietens, KP; Gryseels, C; Jaiteh, F; Mwesigwa, J; O'Neill, S; Ronse, M1
Beeching, NJ; Bell, DJ; Chiodini, PL; Lalloo, DG; Shingadia, D; Whitty, CJM1
Ategeka, J; Awori, P; Charlebois, ED; Clark, TD; Dorsey, G; Feeney, ME; Havlir, DV; Jagannathan, P; Kakuru, A; Kamya, MR; Muehlenbachs, A; Muhindo, MK; Nakalembe, M; Natureeba, P; Nayebare, P; Olwoch, P; Opira, B; Rizzuto, G1
Achieng, F; Desai, M; Hill, J; Hoyt, J; Kariuki, S; L'lanziva, A; Ouma, P; Webster, J1
Cai, X; Cheramy, J; Dezhahang, Z; Poopari, MR; Savin, A; Xu, Y; Zhang, Y1
Ali, D; Faragher, B; Kalilani, L; Kang'ombe, A; Khairallah, C; Levitt, B; Madanitsa, M; Meshnick, S; Mwapasa, V; Pace, C; Smedley, J; Taylor, SM; Ter Kuile, FO; Thwai, KL; van Eijk, AM; Wang, D1
Anh, DT; Ishida, N; Kume, A; Shichiri, M; Suzuki, H1
Elvina, E; Kajeechiwa, L; Kyawt, K; Min, JR; Nosten, F; Nosten, S; Oo, PT; Peapah, P; PoWah, W; Shee, PW; Thwin, MM; von Seidlein, L; Wiladphaingern, J; Yee, NL1
Abdulla, S; Adjei, A; Adjuik, M; Akparibo, R; Ali, AM; Baiden, R; Binka, F; Compaoré, G; Gyapong, M; Kabanywanyi, AM; Kakolwa, MA; Macete, E; Mahende, MK; Oduro, A; Ogutu, BR; Osei, I; Owusu-Agyei, S; Sevene, E; Sie, A; Tinto, H; Valea, I; Yawson, A1
Dorsey, G; Gutman, J; Kovacs, S; Stergachis, A; Ter Kuile, FO1
Aweeka, FT; Chamankhah, N; Dorsey, G; Havlir, D; Huang, L; Jagannathan, P; Kajubi, R; Kakuru, A; Kamya, M; Koss, CA; Mwebaza, N; Rosenthal, PJ; Ruel, T; Were, M1
Duffy, PE; Fried, M1
Dorsey, G; Nosten, F; Price, RN1
Abiodun, O; Bell, A; Brun, R; Chollet, J; Irungu, BN; Kiboi, DM; Langat, B; Nganga, JK; Nyambati, VC; Nzila, A; Rukunga, GM; Wittlin, S1
Donegan, S; Garner, P; Olliaro, P; Sinclair, D; Zani, B1
Aweeka, FT; Huang, L; Jayewardene, AL; Li, X; Lizak, PS; Marzan, F1
D'alessandro, U1
Cairns, M; Cames, C; Cheng, Y; Cisse, B; Faye, B; Faye, E; Faye, O; Gaye, O; Greenwood, B; Lô, AC; Milligan, P; NDiaye, JL; NDiaye, M; NDiaye, O; Simondon, K; Trape, JF1
Bacchieri, A; Bassat, Q; Borrmann, S; Corsi, M; D'Alessandro, U; Menéndez, C; Mulenga, M; Nabasumba, C; Nambozi, M; Piola, P; Sasi, P; Talisuna, A; Tinto, H; Ubben, D; Valéa, I1
Jansen, FH1
Arinaitwe, E; Bigira, V; Creek, D; Dorsey, G; Kakuru, A; Kamya, MR; Sandison, TG; Tappero, J; Wanzira, H1
Govender, K; Meredith, SA; Norman, J; Smith, PJ; Wiesner, L1
Arinaitwe, E; Bigira, V; Dorsey, G; Kakuru, A; Kamya, M; Sandison, T; Tappero, JW; Verret, WJ; Wanzira, H1
Batty, KT; Ilett, KF; Jago, JD; Moore, BR; Page-Sharp, M; Stoney, JR1
Adjalley, SH; Eappen, AG; Eastman, RT; Ekland, EH; Fidock, DA; Hoffman, SL; Johnston, GL; Lee, MC; Li, T; Richman, A; Sim, BK1
Day, NP; Hanpithakpong, W; Lindegardh, N; McGready, R; Nosten, F; Phyo, AP; Rijken, MJ; Tarning, J; White, NJ1
Byakika-Kibwika, P; de Vries, PJ; Hanpithakpong, W; Katabira, E; Lamorde, M; Lindegardh, N; Mayanja-Kizza, H; Mayito, J; Merry, C; Nabukeera, L; Obua, C; Pakker, N; Tarning, J1
Amansyah, F; Dedang, TA; Driyah, S; Ekowatiningsih, R; Hasugian, AR; Januar, L; Labora, J; Prasetyorini, B; Purnama, A; Purnamasari, T; Salwati, E; Siswantoro, H; Tjitra, E; Wijayanto, B; Yusnita, EA; Yuwarni, E1
D'Alessandro, U; Donegan, S; Tudur Smith, C; Williamson, P1
Batty, KT; Bulitta, JB; Gibbons, PL; Kirkpatrick, CM; Moore, BR; Patel, K1
Aung, K; Mak, JW; Naing, C; Wong, JY1
Ariey, F; Beck, HP; Csajka, C; Decosterd, LA; Duong, S; Genton, B; Guidi, M; Kabanywanyi, AM; Olliaro, P; Staehli Hodel, EM1
Baird, JK; Basri, H; Ekawati, LL; Elyazar, I; Farrar, J; Meilia, RA; Nurleila, S; Putri, FA; Setiabudy, R; Sudoyo, H; Sutanto, I; Taylor, WR; Tjahjono, B1
Alpers, MP; Barrett, PH; Bockarie, M; Davis, TM; Dufall, K; Ilett, KF; Karunajeewa, HA; Kemiki, A; Vicini, P1
Chanthap, L; Na-Bangchang, K; Nivanna, N; Socheat, D; Sovannarith, T; Suksom, D; Tsuyuoka, R1
Bojang, K; Bruneton, C; Christophel, EM; Day, NP; Fernandez, F; Green, MD; Greenwood, BM; Kaur, H; Malenga, G; McGready, R; Millet, P; Newton, PN; Nosten, F; Palmer, K; Phanouvong, S; Proux, S; Singhasivanon, P; Sunjio, M; Talisuna, AO; White, NJ; Whitty, CJ1
Godin, B; Golenser, J; Touitou, E; Waknine, JH1
Agbenyega, T; Barnes, KI; Di Perri, G; Folb, P; Gomes, M; Krishna, S; Krudsood, S; Looareesuwan, S; Mansor, S; McIlleron, H; Miller, R; Molyneux, M; Mwenechanya, J; Navaratnam, V; Nosten, F; Olliaro, P; Pang, L; Ribeiro, I; Simpson, JA; Tembo, M; van Vugt, M; Ward, S; Weerasuriya, K; White, NJ; Win, K1
Davis, TM; Ilett, KF; Karunajeewa, HA; Manning, L; Mueller, I1
Barrett, PH; Batty, KT; Davis, TM; Gibbons, PL; Ilett, KF1
Ihongbe, JC; Isibor, J; Okodua, M; Otegbeye, T; Oviasogie, E; Tambo, E; Tatfeng, YM; Tchougang, S1
Anstey, NM; Ebsworth, EP; Hasugian, AR; Kenangalem, E; Laihad, F; Lindegardh, N; Penttinen, P; Price, RN; Purba, HL; Ratcliff, A; Siswantoro, H; Tjitra, E1
Batty, KT; Jago, JD; Moore, BR1
Chaudhary, S; Puri, SK; Singh, C1
Stepniewska, K; White, NJ1
Batty, KT; Davis, TM; Gibbons, PL; Ilett, KF1
Ager, AL; Klayman, DL; Lin, AJ1
Janse, CJ; Kos, J; Lugt, CB; Waters, AP1
Kyle, DE; Lin, AJ; Zikry, AB1
Aguilar, T; Brewer, TG; Grace, JM; Leo, KU; Li, Q; Mitchell, AL; Peggins, J1
Bégué, JP; Bonnet-Delpon, D; Doury, JC; Gantier, JC; Ménage, C; Pradines, B; Thac, TD; Thanh Nga, TT1
Batty, KT; Davis, TM; Edwards, G; Ilett, KF; Maggs, JL; Park, BK; Powell, SM1
MacDonald, RD1
Chen, P; Li, F; Tu, Y; Wang, F; Yang, L1
Du, YL; Li, CS; Zhang, CL; Zhao, XJ1
Li, ZL; Peters, W; Robinson, BL; Warhurst, DC1
Ellis, DS; Gu, HM; Li, ZL; Peters, W; Robinson, BL; Tovey, G; Warhurst, DC1

Reviews

18 review(s) available for artenimol and Malaria

ArticleYear
Spiral molecules with antimalarial activities: A review.
    European journal of medicinal chemistry, 2022, Jul-05, Volume: 237

    Topics: Antimalarials; Drug Resistance; Folic Acid Antagonists; Humans; Malaria; Plasmodium falciparum; Quinolines

2022
Recent advances in malaria drug discovery.
    Bioorganic & medicinal chemistry letters, 2013, May-15, Volume: 23, Issue:10

    Topics: Animals; Antimalarials; Drug Discovery; Humans; Liver; Liver Transplantation; Malaria; Molecular Structure

2013
Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis.
    PloS one, 2022, Volume: 17, Issue:3

    Topics: Africa South of the Sahara; Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Humans; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines

2022
Drug-Drug Interactions of Artemisinin-Based Combination Therapies in Malaria Treatment: A Narrative Review of the Literature.
    Journal of clinical pharmacology, 2022, Volume: 62, Issue:10

    Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum

2022
Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana.
    Frontiers in cellular and infection microbiology, 2022, Volume: 12

    Topics: Antimalarials; Child; Drug Combinations; Ghana; Humans; Malaria; Malaria, Falciparum; Parasitemia; Treatment Outcome

2022
Safety and tolerability of repeated doses of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a systematic review and an aggregated data meta-analysis of randomized controlled trials.
    Malaria journal, 2023, Oct-21, Volume: 22, Issue:1

    Topics: Antimalarials; Drug Combinations; Female; Humans; Infant; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Vomiting

2023
Systematic review of artesunate pharmacokinetics: Implication for treatment of resistant malaria.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2019, Volume: 89

    Topics: Administration, Intravenous; Administration, Oral; Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Drug Monitoring; Drug Resistance; Humans; Malaria; Malaria, Falciparum

2019
The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network.
    PLoS medicine, 2020, Volume: 17, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Female; Humans; Infant; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Middle Aged; Parasitemia; Plasmodium vivax; Young Adult

2020
Malaria PK/PD and the Role Pharmacometrics Can Play in the Global Health Arena: Malaria Treatment Regimens for Vulnerable Populations.
    Clinical pharmacology and therapeutics, 2021, Volume: 110, Issue:4

    Topics: Amodiaquine; Anti-HIV Agents; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child, Preschool; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Female; Global Health; HIV Infections; Humans; Malaria; Malnutrition; Mefloquine; Models, Biological; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinolines; Sulfadoxine; Vulnerable Populations

2021
Intermittent preventive treatment for malaria in infants.
    The Cochrane database of systematic reviews, 2021, 07-17, Volume: 7

    Topics: Africa South of the Sahara; Amodiaquine; Antimalarials; Artemisinins; Bias; Confidence Intervals; Disease Eradication; Drug Combinations; Endemic Diseases; Hospitalization; Humans; Infant; Malaria; Parasitemia; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine

2021
Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: a systematic review and Bayesian meta-analysis.
    The Lancet. Infectious diseases, 2018, Volume: 18, Issue:8

    Topics: Adolescent; Animals; Antimalarials; Artemisinins; Bayes Theorem; Cause of Death; Cohort Studies; Drug Therapy, Combination; Female; Humans; Malaria; Mozambique; Prospective Studies; Quinolines

2018
A systematic review and meta-analysis of dihydroartemisinin-piperaquine versus sulphadoxine-pyrimethamine for malaria prevention in pregnancy.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2019, Volume: 146, Issue:1

    Topics: Adult; Antimalarials; Artemisinins; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine

2019
Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis.
    The Lancet. Infectious diseases, 2017, Volume: 17, Issue:2

    Topics: Antimalarials; Artemisinins; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine

2017
Malaria during Pregnancy.
    Cold Spring Harbor perspectives in medicine, 2017, Jun-01, Volume: 7, Issue:6

    Topics: Africa; Antimalarials; Artemisinins; Drug Combinations; Drug Resistance; Female; Humans; Malaria; Malaria Vaccines; Mefloquine; Placenta; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Sulfadoxine

2017
Artemisinin-based combination therapy for treating uncomplicated malaria.
    The Cochrane database of systematic reviews, 2009, Jul-08, Issue:3

    Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine

2009
Progress in the development of piperaquine combinations for the treatment of malaria.
    Current opinion in infectious diseases, 2009, Volume: 22, Issue:6

    Topics: Adult; Antimalarials; Artemisinins; Child; Clinical Trials as Topic; Drug Combinations; Humans; Malaria; Quinolines

2009
Efficacy and safety of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in endemic countries: meta-analysis of randomised controlled studies.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 2013, Volume: 107, Issue:2

    Topics: Antimalarials; Artemisinins; Drug Combinations; Humans; Malaria; Plasmodium falciparum; Quinolines; Randomized Controlled Trials as Topic; Treatment Failure

2013
Rectal administration of artemisinin derivatives for the treatment of malaria.
    JAMA, 2007, Jun-06, Volume: 297, Issue:21

    Topics: Administration, Rectal; Area Under Curve; Artemether; Artemisinins; Artesunate; Humans; Malaria; Sesquiterpenes

2007

Trials

68 trial(s) available for artenimol and Malaria

ArticleYear
Dihydroartemisinin-Piperaquine Chemoprevention and Malaria Incidence After Severe Flooding: Evaluation of a Pragmatic Intervention in Rural Uganda.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 07-06, Volume: 74, Issue:12

    Topics: Adult; Antimalarials; Artemisinins; Chemoprevention; Child; Floods; Humans; Incidence; Malaria; Piperazines; Quinolines; Uganda

2022
Evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women: protocol of a multicentre, two-arm, randomised, placebo-controlled, superiority clinical trial (MAMAH
    BMJ open, 2021, 11-23, Volume: 11, Issue:11

    Topics: Antimalarials; Artemisinins; Drug Combinations; Female; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Malaria; Multicenter Studies as Topic; Pregnancy; Pregnancy Complications, Parasitic; Pregnant Women; Quinolines; Randomized Controlled Trials as Topic

2021
Piperaquine-Induced QTc Prolongation Decreases With Repeated Monthly Dihydroartemisinin-Piperaquine Dosing in Pregnant Ugandan Women.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 08-31, Volume: 75, Issue:3

    Topics: Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Long QT Syndrome; Malaria; Malaria, Falciparum; Piperazines; Placenta; Pregnancy; Pregnant Women; Quinolines; Uganda

2022
Effect of dihydroartemisinin/piperaquine for malaria intermittent preventive treatment on dolutegravir exposure in pregnant women living with HIV.
    The Journal of antimicrobial chemotherapy, 2022, 05-29, Volume: 77, Issue:6

    Topics: Adult; Antimalarials; Artemisinins; Drug Combinations; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Malaria; Oxazines; Piperazines; Pregnancy; Pregnancy Complications, Parasitic; Pregnant Women; Pyridones; Quinolines

2022
Single low-dose tafenoquine combined with dihydroartemisinin-piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial.
    The Lancet. Microbe, 2022, Volume: 3, Issue:5

    Topics: Aminoquinolines; Animals; Artemisinins; Humans; Malaria; Malaria, Falciparum; Mali; Piperazines; Plasmodium falciparum; Quinolines; Single-Blind Method

2022
Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial.
    PLoS medicine, 2022, Volume: 19, Issue:10

    Topics: Amodiaquine; Anemia, Sickle Cell; Antimalarials; Artemisinins; Chemoprevention; Child; Child, Preschool; Drug Combinations; Female; Humans; Hydroxyurea; Infant; Kenya; Malaria; Malaria, Falciparum; Male; Proguanil; Pyrimethamine; Sulfadoxine

2022
Effect of Malaria and Malaria Chemoprevention Regimens in Pregnancy and Childhood on Neurodevelopmental and Behavioral Outcomes in Children at 12, 24, and 36 Months: A Randomized Clinical Trial.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 02-18, Volume: 76, Issue:4

    Topics: Antimalarials; Artemisinins; Chemoprevention; Child; Drug Combinations; Female; Humans; Malaria; Pregnancy; Pyrimethamine; Quinolines; Sulfadoxine

2023
Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV.
    Antimicrobial agents and chemotherapy, 2022, 12-20, Volume: 66, Issue:12

    Topics: Antimalarials; Female; HIV Infections; Humans; Malaria; Pregnancy; Pregnant Women; Quinolines

2022
Entomological impact of mass administration of ivermectin and dihydroartemisinin-piperaquine in The Gambia: a cluster-randomized controlled trial.
    Parasites & vectors, 2022, Nov-17, Volume: 15, Issue:1

    Topics: Adult; Animals; Anopheles; Artemisinins; Gambia; Humans; Ivermectin; Malaria; Mass Drug Administration; Mosquito Vectors

2022
Implementation research of a cluster randomized trial evaluating the implementation and effectiveness of intermittent preventive treatment for malaria using dihydroartemisinin-piperaquine on reducing malaria burden in school-aged children in Tanzania: met
    Malaria journal, 2023, Jan-06, Volume: 22, Issue:1

    Topics: Antimalarials; Child; Drug Combinations; Humans; Malaria; Quinolines; Tanzania

2023
Impact of population based indoor residual spraying with and without mass drug administration with dihydroartemisinin-piperaquine on malaria prevalence in a high transmission setting: a quasi-experimental controlled before-and-after trial in northeastern
    BMC infectious diseases, 2023, Feb-06, Volume: 23, Issue:1

    Topics: Adolescent; Child; Cross-Sectional Studies; Humans; Insecticides; Malaria; Mass Drug Administration; Mosquito Control; Prevalence; Uganda

2023
Effects of anti-malarial prophylaxes on maternal transfer of Immunoglobulin-G (IgG) and association to immunity against Plasmodium falciparum infections among children in a Ugandan birth cohort.
    PloS one, 2023, Volume: 18, Issue:2

    Topics: Antimalarials; Birth Cohort; Child; Drug Combinations; Female; Humans; Immunoglobulin G; Malaria; Malaria, Falciparum; Placenta; Plasmodium falciparum; Pregnancy; Pyrimethamine; Uganda

2023
Interplay among malnutrition, chemoprevention, and the risk of malaria in young Ugandan children: Longitudinal pharmacodynamic and growth analysis.
    CPT: pharmacometrics & systems pharmacology, 2023, Volume: 12, Issue:5

    Topics: Antimalarials; Child; Child, Preschool; Drug Combinations; HIV Infections; Humans; Infant; Malaria; Malnutrition; Uganda

2023
Dihydroartemisinin-piperaquine or sulphadoxine-pyrimethamine for the chemoprevention of malaria in children with sickle cell anaemia in eastern and southern Africa (CHEMCHA): a protocol for a multi-centre, two-arm, double-blind, randomised, placebo-contro
    Trials, 2023, Apr-05, Volume: 24, Issue:1

    Topics: Africa, Southern; Anemia, Sickle Cell; Antimalarials; Chemoprevention; Child; Drug Combinations; Humans; Malaria; Multicenter Studies as Topic; Quinolines; Randomized Controlled Trials as Topic

2023
Therapeutic response to artemisinin combination therapies among individuals with Plasmodium falciparum single infection vs mixed Plasmodium species infections: a retrospective posthoc analysis in Kisumu County, western Kenya.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2023, Volume: 132

    Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Humans; Kenya; Malaria; Malaria, Falciparum; Plasmodium falciparum; Quinolines; Reinfection; Retrospective Studies

2023
Tafenoquine co-administered with dihydroartemisinin-piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study.
    The Lancet. Infectious diseases, 2023, Volume: 23, Issue:10

    Topics: Antimalarials; Artemisinins; Chloroquine; Drug Therapy, Combination; Humans; Malaria; Malaria, Vivax; Plasmodium vivax; Primaquine; Quinolines

2023
Protocol for a cluster randomised placebo-controlled trial of adjunctive ivermectin mass drug administration for malaria control on the Bijagós Archipelago of Guinea-Bissau: the MATAMAL trial.
    BMJ open, 2023, 07-07, Volume: 13, Issue:7

    Topics: Animals; Antimalarials; Artemisinins; Guinea-Bissau; Humans; Ivermectin; Malaria; Malaria, Falciparum; Mass Drug Administration; Randomized Controlled Trials as Topic

2023
Effectiveness and safety of intermittent preventive treatment with dihydroartemisinin-piperaquine or artesunate-amodiaquine for reducing malaria and related morbidities in schoolchildren in Tanzania: a randomised controlled trial.
    The Lancet. Global health, 2023, Volume: 11, Issue:8

    Topics: Amodiaquine; Antimalarials; Artesunate; Child; COVID-19; Drug Combinations; Hemoglobins; Humans; Incidence; Malaria; Malaria, Falciparum; Quinolines; Tanzania

2023
Efficacy and safety of pyronaridine-artesunate (PYRAMAX) for the treatment of
    BMJ open, 2023, 10-09, Volume: 13, Issue:10

    Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Clinical Trials, Phase III as Topic; Drug Combinations; Female; Humans; Infant; Malaria; Malaria, Falciparum; Pregnancy; Pregnant Women; Randomized Controlled Trials as Topic; Sub-Saharan African People; Treatment Outcome

2023
Intermittent preventive treatment of malaria delivered to primary schoolchildren provided effective individual protection in Jinja, Uganda: secondary outcomes of a cluster-randomized trial (START-IPT).
    Malaria journal, 2019, Sep-18, Volume: 18, Issue:1

    Topics: Adolescent; Anemia; Antimalarials; Artemisinins; Child; Child, Preschool; Cluster Analysis; Drug Combinations; Female; Humans; Malaria; Male; Prevalence; Quinolines; Students; Uganda

2019
Cost-effectiveness of intermittent preventive treatment with dihydroartemisinin-piperaquine versus single screening and treatment for the control of malaria in pregnancy in Papua, Indonesia: a provider perspective analysis from a cluster-randomised trial.
    The Lancet. Global health, 2020, Volume: 8, Issue:12

    Topics: Adult; Antimalarials; Artemisinins; Cluster Analysis; Cost-Benefit Analysis; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Indonesia; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Quinolines

2020
Malaria Chemoprevention in the Postdischarge Management of Severe Anemia.
    The New England journal of medicine, 2020, 12-03, Volume: 383, Issue:23

    Topics: Aftercare; Anemia; Antimalarials; Artemisinins; Child, Preschool; Drug Combinations; Endemic Diseases; Female; Humans; Infant; Kenya; Malaria; Male; Patient Readmission; Quinolines; Uganda

2020
Effect of intermittent preventive treatment for malaria with dihydroartemisinin-piperaquine on immune responses to vaccines among rural Ugandan adolescents: randomised controlled trial protocol B for the '
    BMJ open, 2021, 02-16, Volume: 11, Issue:2

    Topics: Adolescent; Antimalarials; Artemisinins; Drug Combinations; Humans; Immunity; Malaria; Quinolines; Randomized Controlled Trials as Topic; Uganda

2021
Effectiveness of Intermittent Preventive Treatment With Dihydroartemisinin-Piperaqunine Against Malaria in Pregnancy in Tanzania: A Randomized Controlled Trial.
    Clinical pharmacology and therapeutics, 2021, Volume: 110, Issue:6

    Topics: Adult; Antimalarials; Artemisinins; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Quinolines; Single-Blind Method; Tanzania; Treatment Outcome; Young Adult

2021
A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border.
    BMC medicine, 2021, 06-10, Volume: 19, Issue:1

    Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Malaria; Malaria, Falciparum; Mefloquine; Myanmar; Pregnancy; Premature Birth; Quinolines; Thailand

2021
Effectiveness and safety of reactive focal mass drug administration (rfMDA) using dihydroartemisinin-piperaquine to reduce malaria transmission in the very low-endemic setting of Eswatini: a pragmatic cluster randomised controlled trial.
    BMJ global health, 2021, Volume: 6, Issue:6

    Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Eswatini; Humans; Malaria; Mass Drug Administration; Quinolines

2021
The Effect of Intermittent Preventive Treatment of Malaria During Pregnancy and Placental Malaria on Infant Risk of Malaria.
    The Journal of infectious diseases, 2022, 01-18, Volume: 225, Issue:2

    Topics: Adult; Antimalarials; Artemisinins; Drug Combinations; Female; Humans; Infant; Malaria; Malawi; Parasitemia; Piperazines; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinolines; Sulfadoxine; Treatment Outcome

2022
Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine for the Prevention of Malaria Among HIV-Infected Pregnant Women.
    The Journal of infectious diseases, 2017, 07-01, Volume: 216, Issue:1

    Topics: Adult; Antimalarials; Artemisinins; Double-Blind Method; Endpoint Determination; Female; Follow-Up Studies; HIV Infections; Humans; Incidence; Malaria; Pregnancy; Pregnancy Complications, Infectious; Quinolines; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda; Young Adult

2017
Artemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malaria.
    Malaria journal, 2017, 05-16, Volume: 16, Issue:1

    Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Malaria; Mefloquine; Pregnancy; Quinolines; Recurrence; Risk; Treatment Outcome; Young Adult; Zambia

2017
Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    Lancet (London, England), 2018, 04-07, Volume: 391, Issue:10128

    Topics: Adolescent; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Longitudinal Studies; Malaria; Male; Naphthyridines; Quinolines; Young Adult

2018
Assessment of community-level effects of intermittent preventive treatment for malaria in schoolchildren in Jinja, Uganda (START-IPT trial): a cluster-randomised trial.
    The Lancet. Global health, 2018, Volume: 6, Issue:6

    Topics: Adolescent; Antimalarials; Artemisinins; Child; Child, Preschool; Cluster Analysis; Cross-Sectional Studies; Drug Administration Schedule; Drug Combinations; Female; Health Surveys; Humans; Malaria; Male; Prevalence; Quinolines; Residence Characteristics; School Health Services; Treatment Outcome; Uganda; Young Adult

2018
Delivery strategies for malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years old in Malawi: a protocol for a cluster randomized trial.
    BMC pediatrics, 2018, 07-20, Volume: 18, Issue:1

    Topics: Anemia; Antimalarials; Artemisinins; Child, Preschool; Drug Administration Schedule; Humans; Infant; Malaria; Malawi; Medication Adherence; Quinolines

2018
Pharmacokinetics-Pharmacodynamics of High-Dose Ivermectin with Dihydroartemisinin-Piperaquine on Mosquitocidal Activity and QT-Prolongation (IVERMAL).
    Clinical pharmacology and therapeutics, 2019, Volume: 105, Issue:2

    Topics: Adult; Animals; Anopheles; Antimalarials; Artemisinins; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Drug Interactions; Female; Humans; Insecticides; Ivermectin; Kenya; Long QT Syndrome; Malaria; Male; Quinolines; Treatment Outcome

2019
Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: study protocol for a multi-centre, two-arm, randomised, placebo-controlled, sup
    Trials, 2018, Nov-06, Volume: 19, Issue:1

    Topics: Anemia; Artemisinins; Chemoprevention; Child, Preschool; Double-Blind Method; Drug Combinations; Humans; Infant; Infant, Newborn; Kenya; Malaria; Multicenter Studies as Topic; Quinolines; Randomized Controlled Trials as Topic; Sample Size; Uganda

2018
A cluster randomised controlled trial of two rounds of mass drug administration in Zanzibar, a malaria pre-elimination setting-high coverage and safety, but no significant impact on transmission.
    BMC medicine, 2018, 12-10, Volume: 16, Issue:1

    Topics: Antimalarials; Artemisinins; Female; Humans; Incidence; Malaria; Male; Mass Drug Administration; Prevalence; Primaquine; Quinolines; Tanzania

2018
Introducing post-discharge malaria chemoprevention (PMC) for management of severe anemia in Malawian children: a qualitative study of community health workers' perceptions and motivation.
    BMC health services research, 2018, Dec-19, Volume: 18, Issue:1

    Topics: Anemia; Antimalarials; Artemisinins; Attitude of Health Personnel; Caregivers; Chemoprevention; Child; Child, Preschool; Community Health Workers; Drug Combinations; Feasibility Studies; Female; Focus Groups; Government Programs; House Calls; Humans; Infant; Inservice Training; Malaria; Malawi; Male; Motivation; Patient Discharge; Perception; Qualitative Research; Quinolines; Workload

2018
Community perspectives on treating asymptomatic infections for malaria elimination in The Gambia.
    Malaria journal, 2019, Feb-18, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Antimalarials; Artemisinins; Asymptomatic Infections; Child; Child, Preschool; Cross-Sectional Studies; Disease Eradication; Female; Gambia; Humans; Infant; Infant, Newborn; Malaria; Male; Patient Acceptance of Health Care; Quinolines; Young Adult

2019
Efficacy of artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria among children in Rwanda: an open-label, randomized controlled trial.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 2019, 06-01, Volume: 113, Issue:6

    Topics: Adolescent; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Female; Humans; Infant; Malaria; Male; Quinolines; Rwanda

2019
Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants.
    The Journal of infectious diseases, 2013, Jun-01, Volume: 207, Issue:11

    Topics: Antimalarials; Artemisinins; Chemoprevention; Female; Follow-Up Studies; Humans; Infant; Malaria; Male; Plasma; Prospective Studies; Quinolines; Secondary Prevention; Time Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda

2013
Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in Ugandan schoolchildren: a randomized, placebo-controlled trial.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Volume: 58, Issue:10

    Topics: Anemia; Antimalarials; Artemisinins; Child; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Malaria; Malaria, Falciparum; Male; Parasitemia; Prevalence; Quinolines; Risk Factors; Uganda

2014
Artemisinin-based combination therapies are efficacious and safe for treatment of uncomplicated malaria in HIV-infected Ugandan children.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Aug-01, Volume: 59, Issue:3

    Topics: Antimalarials; Artemisinins; Child, Preschool; Cohort Studies; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant; Lopinavir; Malaria; Male; Nevirapine; Parasitemia; Quinolines; Reverse Transcriptase Inhibitors; Ritonavir; Treatment Outcome; Uganda

2014
Effect of coadministered fat on the tolerability, safety, and pharmacokinetic properties of dihydroartemisinin-piperaquine in Papua New Guinean children with uncomplicated malaria.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:10

    Topics: Antimalarials; Artemisinins; Child; Female; Hemodynamics; Humans; Malaria; Male; Quinolines

2014
Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:10

    Topics: Adult; Antimalarials; Arrhythmias, Cardiac; Artemisinins; Double-Blind Method; Female; Humans; Malaria; Male; Quinolines; Young Adult

2014
Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trial.
    PLoS medicine, 2014, Volume: 11, Issue:8

    Topics: Antimalarials; Artemisinins; Cohort Studies; Drug Combinations; Female; Humans; Incidence; Infant; Malaria; Male; Pyrimethamine; Quinolines; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda

2014
Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial.
    AIDS (London, England), 2014, Nov-28, Volume: 28, Issue:18

    Topics: Antimalarials; Artemisinins; Chemoprevention; Child, Preschool; Cohort Studies; Drug Combinations; Female; Humans; Infant; Malaria; Male; Pyrimethamine; Quinolines; Sulfadoxine; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda

2014
Safe and efficacious artemisinin-based combination treatments for African pregnant women with malaria: a multicentre randomized control trial.
    Reproductive health, 2015, Jan-15, Volume: 12

    Topics: Adult; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Birth Weight; Burkina Faso; Drug Combinations; Ethanolamines; Female; Fetal Development; Fluorenes; Follow-Up Studies; Ghana; Humans; Infant, Newborn; Malaria; Malawi; Mefloquine; Placentation; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Exposure Delayed Effects; Quinolines; Zambia

2015
Perceptions and utilization of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine in young children in the Chikhwawa District of Malawi: a mixed methods study.
    Malaria journal, 2015, Jan-21, Volume: 14

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Drug Combinations; Drug Utilization; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria; Malawi; Male; Medication Adherence; Quinolines; Surveys and Questionnaires

2015
Opposite malaria and pregnancy effect on oral bioavailability of artesunate - a population pharmacokinetic evaluation.
    British journal of clinical pharmacology, 2015, Volume: 80, Issue:4

    Topics: Administration, Intravenous; Administration, Oral; Antimalarials; Artemisinins; Artesunate; Biological Availability; Female; Humans; Malaria; Models, Biological; Postpartum Period; Pregnancy; Pregnancy Complications, Parasitic

2015
Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8

    Topics: Amodiaquine; Antimalarials; Artemisinins; Burkina Faso; Case-Control Studies; Chemoprevention; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infant; Malaria; Male; Pyrimethamine; Quinolines; Seasons; Sulfadoxine

2015
Assessing the effectiveness of household-level focal mass drug administration and community-wide mass drug administration for reducing malaria parasite infection prevalence and incidence in Southern Province, Zambia: study protocol for a community randomi
    Trials, 2015, Aug-13, Volume: 16

    Topics: Antimalarials; Artemisinins; Catchment Area, Health; Child, Preschool; Community Health Services; Cross-Sectional Studies; Drug Combinations; Health Facilities; Humans; Incidence; Infant; Longitudinal Studies; Malaria; Mass Screening; Prevalence; Program Evaluation; Quinolines; Research Design; Seasons; Time Factors; Treatment Outcome; Zambia

2015
Variable piperaquine exposure significantly impacts protective efficacy of monthly dihydroartemisinin-piperaquine for the prevention of malaria in Ugandan children.
    Malaria journal, 2015, Sep-24, Volume: 14

    Topics: Adolescent; Adult; Antimalarials; Artemisinins; Chemoprevention; Child, Preschool; Disease Transmission, Infectious; Female; Humans; Infant; Malaria; Male; Quinolines; Random Allocation; Treatment Outcome; Uganda; Young Adult

2015
Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-lab
    Lancet (London, England), 2015, Dec-19, Volume: 386, Issue:10012

    Topics: Adolescent; Adult; Antimalarials; Artemisinins; Drug Combinations; Drug Therapy, Combination; Female; Humans; Kenya; Malaria; Mass Screening; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Diagnosis; Pyrimethamine; Quinolines; Risk Factors; Sulfadoxine; Treatment Outcome; Young Adult

2015
Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial.
    Tropical medicine & international health : TM & IH, 2016, Volume: 21, Issue:2

    Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Chemoprevention; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Ghana; Humans; Infant; Infant, Newborn; Lumefantrine; Malaria; Male; Pyrimethamine; Quinolines; Rain; Seasons; Sulfadoxine

2016
Antibody profiles to plasmodium merozoite surface protein-1 in Cambodian adults during an active surveillance cohort with nested treatment study.
    Malaria journal, 2016, Jan-08, Volume: 15

    Topics: Adult; Antibodies, Protozoan; Antigens, Protozoan; Artemisinins; Enzyme-Linked Immunosorbent Assay; Female; Humans; Malaria; Malaria, Falciparum; Male; Merozoite Surface Protein 1; Plasmodium falciparum; Plasmodium vivax; Young Adult

2016
Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy.
    The New England journal of medicine, 2016, Mar-10, Volume: 374, Issue:10

    Topics: Adolescent; Adult; Antimalarials; Artemisinins; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Humans; Incidence; Malaria; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Quinolines; Sulfadoxine; Uganda; Vomiting; Young Adult

2016
User and Provider Acceptability of Intermittent Screening and Treatment and Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine to Prevent Malaria in Pregnancy in Western Kenya.
    PloS one, 2016, Volume: 11, Issue:3

    Topics: Adolescent; Adult; Antimalarials; Artemisinins; Female; Humans; Kenya; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Quinolines; Young Adult

2016
Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Tr
    PLoS medicine, 2016, Volume: 13, Issue:9

    Topics: Adolescent; Adult; Antimalarials; Artemisinins; Diagnostic Tests, Routine; Drug Combinations; Female; Humans; Malaria; Malawi; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Quinolines; Sulfadoxine; Young Adult

2016
Antiretroviral Therapy With Efavirenz Accentuates Pregnancy-Associated Reduction of Dihydroartemisinin-Piperaquine Exposure During Malaria Chemoprevention.
    Clinical pharmacology and therapeutics, 2017, Volume: 102, Issue:3

    Topics: Adolescent; Adult; Alkynes; Antimalarials; Area Under Curve; Artemisinins; Benzoxazines; Chemoprevention; Cyclopropanes; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Female; HIV Infections; Humans; Malaria; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Complications, Parasitic; Quinolines; Reverse Transcriptase Inhibitors; Uganda; Young Adult

2017
Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children.
    PloS one, 2009, Sep-28, Volume: 4, Issue:9

    Topics: Antimalarials; Artemisinins; Child, Preschool; Cluster Analysis; Drug Combinations; Female; Humans; Incidence; Infant; Malaria; Male; Pyrimethamine; Quinolines; Rural Population; Senegal; Sulfadoxine; Treatment Outcome

2009
Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial.
    PloS one, 2009, Nov-17, Volume: 4, Issue:11

    Topics: Africa; Antiparasitic Agents; Artemether; Artemisinins; Child, Preschool; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Malaria, Falciparum; Plasmodium falciparum; Polymerase Chain Reaction; Quinolines; Time Factors

2009
Increased risk of early vomiting among infants and young children treated with dihydroartemisinin-piperaquine compared with artemether-lumefantrine for uncomplicated malaria.
    The American journal of tropical medicine and hygiene, 2010, Volume: 83, Issue:4

    Topics: Antimalarials; Artemether; Artemisinins; Child, Preschool; Ethanolamines; Fluorenes; Humans; Infant; Lumefantrine; Malaria; Quinolines; Risk; Uganda; Vomiting

2010
Effect of nutritional status on response to treatment with artemisinin-based combination therapy in young Ugandan children with malaria.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:6

    Topics: Antimalarials; Artemisinins; Drug Therapy, Combination; Humans; Infant; Malaria; Malnutrition; Parasitemia; Quinolines

2011
Pharmacokinetics and pharmacodynamics of intravenous artesunate during severe malaria treatment in Ugandan adults.
    Malaria journal, 2012, Apr-27, Volume: 11

    Topics: Adult; Antimalarials; Artemisinins; Artesunate; Chromatography, Liquid; Female; Humans; Injections, Intravenous; Malaria; Male; Plasma; Tandem Mass Spectrometry; Uganda

2012
Efficacy and safety of artemisinin-naphthoquine versus dihydroartemisinin-piperaquine in adult patients with uncomplicated malaria: a multi-centre study in Indonesia.
    Malaria journal, 2012, Jun-14, Volume: 11

    Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; DNA, Protozoan; Female; Humans; Indonesia; Malaria; Male; Middle Aged; Naphthoquinones; Parasitemia; Polymerase Chain Reaction; Quinolines; Treatment Outcome; Young Adult

2012
Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:3

    Topics: Adult; Antimalarials; Artemisinins; Artesunate; Drug Administration Schedule; Drug Dosage Calculations; Drug Resistance; Drug Therapy, Combination; Humans; Indonesia; Malaria; Malaria, Vivax; Male; Military Personnel; Plasmodium vivax; Primaquine; Quinine; Quinolines; Secondary Prevention

2013
Disposition of artesunate and dihydroartemisinin after administration of artesunate suppositories in children from Papua New Guinea with uncomplicated malaria.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:8

    Topics: Aging; alpha-Thalassemia; Antimalarials; Artemisinins; Artesunate; Body Weight; Child; Chromatography, High Pressure Liquid; Female; Genotype; Half-Life; Humans; Malaria; Male; Models, Statistical; Papua New Guinea; Population; Sesquiterpenes; Sex Characteristics; Spectrometry, Mass, Electrospray Ionization; Suppositories; Tissue Distribution

2004
Investigation of bioavailability, pharmacokinetics and safety of new pediatric formulations of artesunate and mefloquine.
    The Southeast Asian journal of tropical medicine and public health, 2005, Volume: 36, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Antimalarials; Artemisinins; Artesunate; Biological Availability; Drug Therapy, Combination; Humans; Malaria; Male; Mefloquine; Pediatrics; Sesquiterpenes

2005
Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11

    Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Indonesia; Infant; Malaria; Male; Middle Aged; Prospective Studies; Quinolines; Sesquiterpenes; Survival Analysis; Treatment Outcome

2007

Other Studies

128 other study(ies) available for artenimol and Malaria

ArticleYear
Enantioselective Synthesis and in Vivo Evaluation of Regioisomeric Analogues of the Antimalarial Arterolane.
    Journal of medicinal chemistry, 2017, 07-27, Volume: 60, Issue:14

    Topics: Animals; Antimalarials; Female; Ferrous Compounds; Heterocyclic Compounds, 1-Ring; Malaria; Mice; Peroxides; Plasmodium berghei; Plasmodium falciparum; Spiro Compounds; Stereoisomerism; Structure-Activity Relationship

2017
Plasmodial Kinase Inhibitors: License to Cure?
    Journal of medicinal chemistry, 2018, 09-27, Volume: 61, Issue:18

    Topics: Antimalarials; Humans; Malaria; Plasmodium; Protein Kinase Inhibitors; Protein Kinases

2018
Lead Optimization of Second-Generation Acridones as Broad-Spectrum Antimalarials.
    Journal of medicinal chemistry, 2020, 06-11, Volume: 63, Issue:11

    Topics: Acridones; Administration, Oral; Animals; Antimalarials; Cell Survival; Disease Models, Animal; Female; Half-Life; Hep G2 Cells; Humans; Life Cycle Stages; Malaria; Male; Mice; Mice, Inbred C57BL; Plasmodium falciparum; Structure-Activity Relationship

2020
Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials.
    European journal of medicinal chemistry, 2021, Aug-05, Volume: 220

    Topics: Antimalarials; Artemisinins; Cysteine Endopeptidases; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Heme; Malaria; Molecular Structure; Organophosphonates; Parasitic Sensitivity Tests; Peptides; Plasmodium falciparum; Polymerization; Structure-Activity Relationship; Vinyl Compounds

2021
Aminoalkoxycarbonyloxymethyl Ether Prodrugs with a pH-Triggered Release Mechanism: A Case Study Improving the Solubility, Bioavailability, and Efficacy of Antimalarial 4(1
    Journal of medicinal chemistry, 2021, 05-27, Volume: 64, Issue:10

    Topics: Administration, Oral; Animals; Antimalarials; Cyclization; Disease Models, Animal; Ethers; Female; Half-Life; Hydrogen-Ion Concentration; Malaria; Mice; Mice, Inbred BALB C; Plasmodium falciparum; Prodrugs; Quinolones; Solubility; Structure-Activity Relationship

2021
Antimalarial activity of new water-soluble dihydroartemisinin derivatives. 2. Stereospecificity of the ether side chain.
    Journal of medicinal chemistry, 1989, Volume: 32, Issue:6

    Topics: Animals; Artemisinins; Chemical Phenomena; Chemistry; Malaria; Mice; Molecular Structure; Plasmodium falciparum; Sesquiterpenes; Solubility; Stereoisomerism; Structure-Activity Relationship; Water

1989
Arteether, a new antimalarial drug: synthesis and antimalarial properties.
    Journal of medicinal chemistry, 1988, Volume: 31, Issue:3

    Topics: Animals; Antimalarials; Artemisinins; Magnetic Resonance Spectroscopy; Malaria; Mice; Models, Molecular; Plasmodium berghei; Plasmodium falciparum; Sesquiterpenes

1988
Synthesis and antimalarial activity of sixteen dispiro-1,2,4, 5-tetraoxanes: alkyl-substituted 7,8,15,16-tetraoxadispiro[5.2.5. 2]hexadecanes.
    Journal of medicinal chemistry, 2000, Jul-13, Volume: 43, Issue:14

    Topics: Alkanes; Animals; Antimalarials; Malaria; Mice; Neurites; Neuroblastoma; Plasmodium berghei; Plasmodium falciparum; Spiro Compounds; Structure-Activity Relationship; Tumor Cells, Cultured

2000
Synthesis, antimalarial activity, biomimetic iron(II) chemistry, and in vivo metabolism of novel, potent C-10-phenoxy derivatives of dihydroartemisinin.
    Journal of medicinal chemistry, 2001, Jan-04, Volume: 44, Issue:1

    Topics: Animals; Antimalarials; Artemisinins; Bile; Crystallography, X-Ray; Electron Spin Resonance Spectroscopy; Ferrous Compounds; Free Radicals; Malaria; Male; Mice; Phenyl Ethers; Plasmodium berghei; Plasmodium falciparum; Plasmodium yoelii; Rats; Rats, Wistar; Sesquiterpenes; Stereoisomerism; Structure-Activity Relationship

2001
Spiro and dispiro-1,2,4-trioxolanes as antimalarial peroxides: charting a workable structure-activity relationship using simple prototypes.
    Journal of medicinal chemistry, 2005, Jul-28, Volume: 48, Issue:15

    Topics: Adamantane; Animals; Antimalarials; Cell Line, Tumor; Drug Resistance; Half-Life; Malaria; Malaria, Falciparum; Mice; Micronucleus Tests; Ozone; Peroxides; Plasmodium berghei; Rats; Spiro Compounds; Structure-Activity Relationship

2005
Pharmacodynamics of doxycycline in a murine malaria model.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12

    Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Doxycycline; Drug Synergism; Drug Therapy, Combination; Malaria; Male; Mice; Mice, Inbred BALB C; Plasmodium berghei; Sesquiterpenes

2007
Pharmacokinetics and pharmacodynamics of piperaquine in a murine malaria model.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:1

    Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Drug Therapy, Combination; Humans; Malaria; Male; Mice; Parasitemia; Plasmodium berghei; Quinolines; Sesquiterpenes; Treatment Outcome

2008
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
    Proceedings of the National Academy of Sciences of the United States of America, 2008, Jul-01, Volume: 105, Issue:26

    Topics: Animals; Antimalarials; Cluster Analysis; Computational Biology; Drug Evaluation, Preclinical; Drug Resistance; Folic Acid Antagonists; Malaria; Models, Molecular; Parasites; Plasmodium falciparum; Reproducibility of Results; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase

2008
Synthesis and evaluation of hybrid drugs for a potential HIV/AIDS-malaria combination therapy.
    Bioorganic & medicinal chemistry, 2012, Sep-01, Volume: 20, Issue:17

    Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; Antimalarials; Dose-Response Relationship, Drug; Drug Therapy, Combination; HeLa Cells; HIV Infections; HIV-1; Humans; Malaria; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship

2012
Orally bioavailable 6-chloro-7-methoxy-4(1H)-quinolones efficacious against multiple stages of Plasmodium.
    Journal of medicinal chemistry, 2014, Nov-13, Volume: 57, Issue:21

    Topics: Animals; Antimalarials; Humans; Inhibitory Concentration 50; Malaria; Mice; Microsomes, Liver; Parasitemia; Plasmodium; Plasmodium berghei; Quinolones; Structure-Activity Relationship

2014
Hydroxamic acid based histone deacetylase inhibitors with confirmed activity against the malaria parasite.
    Bioorganic & medicinal chemistry letters, 2015, Feb-01, Volume: 25, Issue:3

    Topics: Animals; Antimalarials; Cell Line, Tumor; Dipeptides; Disease Models, Animal; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Malaria; Mice; Parasites; Plasmodium falciparum; Protein Isoforms

2015
Mass drug administration of ivermectin and dihydroartemisinin-piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised controlled trial in The Gambia.
    The Lancet. Infectious diseases, 2022, Volume: 22, Issue:4

    Topics: Animals; Antimalarials; Artemisinins; Gambia; Humans; Ivermectin; Malaria; Mass Drug Administration; Mosquito Vectors; Piperazines; Quinolines

2022
Ferroptosis plays an essential role in the antimalarial mechanism of low-dose dihydroartemisinin.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 148

    Topics: Animals; Antimalarials; Artemisinins; Cell Death; Female; Ferroptosis; Humans; Malaria; Mice; Mice, Inbred C57BL; Parasites; Piperazines; Reactive Oxygen Species; Sorafenib

2022
Observation of Malaria Treatment with Dihydroartemisinin-Piperaquine Combination at Primary Health Care
    Turkiye parazitolojii dergisi, 2022, 05-23, Volume: 46, Issue:2

    Topics: Antimalarials; Artemisinins; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Piperazines; Primary Health Care; Quinolines; Treatment Outcome

2022
Artesunate and dihydroartemisinin-piperaquine treatment failure in a severe Plasmodium falciparum malaria case imported from Republic of Côte d'Ivoire.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2022, Volume: 122

    Topics: Aged; Antimalarials; Artemisinins; Artesunate; Cote d'Ivoire; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Male; Piperazines; Plasmodium falciparum; Quinolines; Treatment Failure

2022
Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria among Children in Western Kenya, 2016 to 2017.
    Antimicrobial agents and chemotherapy, 2022, 09-20, Volume: 66, Issue:9

    Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ethanolamines; Fluorenes; Folic Acid Antagonists; Humans; Infant; Kenya; Malaria; Malaria, Falciparum; Piperazines; Plasmodium falciparum; Quinolines; Reinfection

2022
Antimalarial Efficacy of Aqueous Extract of Strychnos ligustrina and Its Combination with Dihydroartemisinin and Piperaquine Phosphate (DHP) against Plasmodium berghei Infection.
    The Korean journal of parasitology, 2022, Volume: 60, Issue:5

    Topics: Animals; Antimalarials; Artemisinins; Malaria; Mice; Mice, Inbred BALB C; Phosphates; Plant Extracts; Plasmodium berghei; Strychnos

2022
Therapeutic efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium vivax malaria in Seacha area, Arbaminch Zuria District, South West Ethiopia.
    Malaria journal, 2022, Nov-27, Volume: 21, Issue:1

    Topics: Antimalarials; Artemisinins; Ethiopia; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax

2022
A Plasmodium falciparum ubiquitin-specific protease (PfUSP) is essential for parasite survival and its disruption enhances artemisinin efficacy.
    The Biochemical journal, 2023, 01-13, Volume: 480, Issue:1

    Topics: Animals; Antimalarials; Artemisinins; Drug Resistance; Humans; Malaria; Parasites; Plasmodium falciparum; Proteasome Endopeptidase Complex; Ubiquitin; Ubiquitin-Specific Proteases

2023
Assessment of artemisinin tolerance in Plasmodium falciparum clinical isolates in children with uncomplicated malaria in Ghana.
    Malaria journal, 2023, Feb-19, Volume: 22, Issue:1

    Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Drug Tolerance; Ghana; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Plasmodium falciparum

2023
Comparative efficacy of sulphadoxine-pyrimethamine and dihydroartemisinin-piperaquine against malaria infection during late-stage pregnancy in mice.
    Experimental parasitology, 2023, Volume: 248

    Topics: Animals; Antimalarials; Drug Combinations; Drug Therapy, Combination; Female; Malaria; Malaria, Falciparum; Mice; Plasmodium berghei; Pregnancy; Pyrimethamine

2023
Design, Implementation, and Coordination of Malaria Therapeutic Efficacy Studies in Nigeria in 2018.
    The American journal of tropical medicine and hygiene, 2023, 06-07, Volume: 108, Issue:6

    Topics: Amodiaquine; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Child; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Malaria, Falciparum; Nigeria

2023
Prevalence of mutations in the cysteine desulfurase IscS (Pfnfs1) gene in recurrent Plasmodium falciparum infections following artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) treatment in Matayos, Western Kenya.
    Malaria journal, 2023, May-19, Volume: 22, Issue:1

    Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Drug Combinations; Humans; Kenya; Lumefantrine; Malaria; Malaria, Falciparum; Mutation; Plasmodium falciparum; Prevalence; Quinolines; Reinfection

2023
Effectiveness of dihydroartemisinin-piperaquine after 10 years as treatment for vivax malaria in Indonesia.
    Journal of infection in developing countries, 2023, 05-31, Volume: 17, Issue:5

    Topics: Adult; Antimalarials; Child; Humans; Indonesia; Malaria; Malaria, Falciparum; Malaria, Vivax; Prospective Studies

2023
Dihydroartemisinin Disrupts Zinc Homeostasis in
    ACS infectious diseases, 2023, 07-14, Volume: 9, Issue:7

    Topics: Animals; Antimalarials; Artemisinins; Folic Acid Antagonists; Glutathione; Homeostasis; Humans; Malaria; Malaria, Falciparum; Parasites; Plasmodium falciparum

2023
A comprehensive approach to optimizing malaria prevention in pregnant women: evaluating the efficacy, cost-effectiveness, and resistance of IPTp-SP and IPTp-DP.
    Global health action, 2023, 12-31, Volume: 16, Issue:1

    Topics: Antimalarials; Cost-Benefit Analysis; Female; Humans; Malaria; Pregnancy; Pregnant Women

2023
Evolution of genetic markers for drug resistance after the introduction of dihydroartemisinin-piperaquine as first-line anti-malarial treatment for uncomplicated falciparum malaria in Indonesia.
    Malaria journal, 2023, Aug-09, Volume: 22, Issue:1

    Topics: Antimalarials; DNA Copy Number Variations; Drug Resistance; Genetic Markers; Humans; Indonesia; Malaria; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins

2023
Variation in neutrophil levels and artemisinin-based combination therapy efficacy in West-Africa.
    Journal of infection in developing countries, 2023, 09-30, Volume: 17, Issue:9

    Topics: Africa; Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Drug Combinations; Ethanolamines; Humans; Malaria; Malaria, Falciparum; Neutropenia; Neutrophils; Parasitemia; Plasmodium falciparum; Prospective Studies

2023
Implementing population-based mass drug administration for malaria: experience from a high transmission setting in North Eastern Uganda.
    Malaria journal, 2019, Aug-09, Volume: 18, Issue:1

    Topics: Antimalarials; Artemisinins; Community Participation; Drug Combinations; Malaria; Mass Drug Administration; Quinolines; Uganda

2019
Effect of Dihydroartemisinin on
    The American journal of Chinese medicine, 2019, Volume: 47, Issue:6

    Topics: Animals; Antimalarials; Artemisinins; Azaserine; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression; Glutamate Synthase (NADH); Glutamic Acid; Humans; Malaria; Mice, Inbred C57BL; Phytotherapy; Plasmodium falciparum

2019
Safety, Pharmacokinetics, and Mosquito-Lethal Effects of Ivermectin in Combination With Dihydroartemisinin-Piperaquine and Primaquine in Healthy Adult Thai Subjects.
    Clinical pharmacology and therapeutics, 2020, Volume: 107, Issue:5

    Topics: Adolescent; Adult; Animals; Anopheles; Antimalarials; Artemisinins; Drug Interactions; Drug Therapy, Combination; Female; Humans; Insecticides; Ivermectin; Malaria; Male; Middle Aged; Primaquine; Quinolines; Thailand; Young Adult

2020
Intravenous artesunate plus oral dihydroartemisinin-piperaquine or intravenous quinine plus oral quinine for optimum treatment of severe malaria: lesson learnt from a field hospital in Timika, Papua, Indonesia.
    Malaria journal, 2019, Dec-30, Volume: 18, Issue:1

    Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Female; Humans; Indonesia; Infant; Infant, Newborn; Malaria; Male; Middle Aged; Quinine; Quinolines; Retrospective Studies; Young Adult

2019
Efavirenz-Based Antiretroviral Therapy Reduces Artemether-Lumefantrine Exposure for Malaria Treatment in HIV-Infected Pregnant Women.
    Journal of acquired immune deficiency syndromes (1999), 2020, 02-01, Volume: 83, Issue:2

    Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Anti-Retroviral Agents; Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Benzoxazines; Cyclopropanes; Drug Combinations; Drug Interactions; Female; HIV Infections; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Pregnancy; Prospective Studies; Uganda; Young Adult

2020
Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study.
    The Lancet. Infectious diseases, 2020, Volume: 20, Issue:4

    Topics: Animals; Antimalarials; Artemisinins; Burkina Faso; Child; Female; Humans; Incidence; Insecticides; Ivermectin; Malaria; Male; Mass Drug Administration; Mosquito Vectors; Prevalence; Quinolines; Randomized Controlled Trials as Topic; Seasons

2020
Effect of mass dihydroartemisinin-piperaquine administration in southern Mozambique on the carriage of molecular markers of antimalarial resistance.
    PloS one, 2020, Volume: 15, Issue:10

    Topics: Antimalarials; Artemisinins; Drug Combinations; Drug Resistance; Malaria; Mozambique; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Quinolines

2020
Cost-effectiveness of intermittent preventive treatment with dihydroartemisinin-piperaquine for malaria during pregnancy: an analysis using efficacy results from Uganda and Kenya, and pooled data.
    The Lancet. Global health, 2020, Volume: 8, Issue:12

    Topics: Adult; Antimalarials; Artemisinins; Cost-Benefit Analysis; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Kenya; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Quinolines; Therapeutics; Uganda; Young Adult

2020
Intermittent screening and treatment with dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy: implementation feasibility in a routine healthcare system setting in western Kenya.
    Malaria journal, 2020, Nov-25, Volume: 19, Issue:1

    Topics: Adolescent; Adult; Antimalarials; Artemisinins; Diagnostic Tests, Routine; Drug Combinations; Feasibility Studies; Female; Humans; Kenya; Malaria; Mass Screening; Middle Aged; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Quinolines; Young Adult

2020
Understanding adherence to reactive treatment of asymptomatic malaria infections in The Gambia.
    Scientific reports, 2021, 01-18, Volume: 11, Issue:1

    Topics: Adolescent; Adult; Antimalarials; Artemisinins; Asymptomatic Infections; Child; Child, Preschool; Female; Gambia; Humans; Infant; Infant, Newborn; Malaria; Male; Medication Adherence; Patient Compliance; Plasmodium malariae; Quinolines; Young Adult

2021
A tablet derived from
    Journal of basic and clinical physiology and pharmacology, 2021, Feb-11, Volume: 33, Issue:2

    Topics: Andrographis paniculata; Animals; Artemisinins; Female; Malaria; Mice; Mice, Inbred BALB C; Piperazines; Placenta; Pregnancy; Quinolines; Tablets

2021
Electrocardiographic effect of artemisinin-piperaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine treatment in falciparum malaria patients.
    Revista da Sociedade Brasileira de Medicina Tropical, 2021, Volume: 54

    Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Drug Combinations; Electrocardiography; Humans; Malaria; Malaria, Falciparum; Quinolines

2021
Effect of Body Weight and Age on the Pharmacokinetics of Dihydroartemisinin: Food and Drug Administration Basis for Dose Determination of Artesunate for Injection in Pediatric Patients With Severe Malaria.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 09-07, Volume: 73, Issue:5

    Topics: Antimalarials; Artemisinins; Artesunate; Body Weight; Child; Humans; Malaria; Malaria, Falciparum; United States; United States Food and Drug Administration

2021
Effect of α-tocopheryloxy acetic acid, a vitamin E derivative mitocan, on the experimental infection of mice with Plasmodium yoelii.
    Malaria journal, 2021, Jun-24, Volume: 20, Issue:1

    Topics: Administration, Oral; Animals; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Therapy, Combination; Injections, Intraperitoneal; Malaria; Mice; Mice, Inbred C57BL; Plasmodium yoelii; Tocopherols

2021
Murine pharmacokinetics and antimalarial pharmacodynamics of dihydroartemisinin trimer self-assembled nanoparticles.
    Parasitology research, 2021, Volume: 120, Issue:8

    Topics: Animals; Antimalarials; Artemisinins; Artesunate; Malaria; Mice; Nanoparticles; Plasmodium yoelii; Rats

2021
Efficacy of dihydroartemisinin/piperaquine in patients with non-complicated Plasmodium falciparum malaria in Yaoundé, Cameroon.
    The Journal of antimicrobial chemotherapy, 2021, 10-11, Volume: 76, Issue:11

    Topics: Antimalarials; Artemisinins; Cameroon; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum; Quinolines

2021
Intermittent preventive treatment for malaria among children in a refugee camp in Northern Uganda: lessons learned.
    Malaria journal, 2017, 05-23, Volume: 16, Issue:1

    Topics: Adolescent; Antimalarials; Artemisinins; Child; Child, Preschool; Cross-Sectional Studies; Drug Combinations; Female; Humans; Incidence; Infant; Malaria; Male; Parasitemia; Prevalence; Quinolines; Refugee Camps; Uganda

2017
Ex vivo susceptibility and genotyping of Plasmodium falciparum isolates from Pikine, Senegal.
    Malaria journal, 2017, 06-14, Volume: 16, Issue:1

    Topics: Adolescent; Amodiaquine; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Resistance; Fluorescent Dyes; Genotype; Genotyping Techniques; Humans; Indoles; Inhibitory Concentration 50; Malaria; Mutation; Parasitic Sensitivity Tests; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pyrimethamine; Quinolines; Senegal; Young Adult

2017
Synergistic blending of high-valued heterocycles inhibits growth of Plasmodium falciparum in culture and P. berghei infection in mouse model.
    Scientific reports, 2017, 07-27, Volume: 7, Issue:1

    Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Erythrocytes; Female; Humans; Inhibitory Concentration 50; Life Cycle Stages; Malaria; Mice; Phthalimides; Plasmodium berghei; Plasmodium falciparum

2017
A thiol probe for measuring unfolded protein load and proteostasis in cells.
    Nature communications, 2017, 09-07, Volume: 8, Issue:1

    Topics: Animals; Artemisinins; Cells; Cysteine; Fluorescent Dyes; HEK293 Cells; HeLa Cells; Humans; Huntingtin Protein; Malaria; Maleimides; Mice; Molecular Probes; Mutant Proteins; Oligopeptides; Parasites; Protein Folding; Proteome; Proteostasis; Solubility; Sulfhydryl Compounds; Tunicamycin

2017
Response to "Antiretroviral Therapy With Efavirenz in HIV-Infected Pregnant Women: Understanding the Possible Mechanisms for Drug-Drug Interaction".
    Clinical pharmacology and therapeutics, 2018, Volume: 103, Issue:4

    Topics: Alkynes; Artemisinins; Benzoxazines; Chemoprevention; Cyclopropanes; Drug Interactions; Female; HIV; HIV Infections; Humans; Malaria; Pregnancy; Quinolines

2018
Antiretroviral Therapy With Efavirenz in HIV-Infected Pregnant Women: Understanding the Possible Mechanisms for Drug-Drug Interaction.
    Clinical pharmacology and therapeutics, 2018, Volume: 103, Issue:4

    Topics: Alkynes; Artemisinins; Benzoxazines; Chemoprevention; Cyclopropanes; Drug Interactions; Female; HIV; HIV Infections; Humans; Malaria; Pregnancy; Quinolines

2018
Ivermectin: repurposing an old drug to complement malaria vector control.
    The Lancet. Infectious diseases, 2018, Volume: 18, Issue:6

    Topics: Animals; Artemisinins; Double-Blind Method; Drug Repositioning; Ivermectin; Kenya; Malaria; Mosquito Vectors; Quinolines

2018
Reappraising the cardiosafety of dihydroartemisinin-piperaquine.
    The Lancet. Infectious diseases, 2018, Volume: 18, Issue:8

    Topics: Artemisinins; Bayes Theorem; Humans; Malaria; Quinolines

2018
Misdiagnosis of Babesiosis as Malaria, Equatorial Guinea, 2014.
    Emerging infectious diseases, 2018, Volume: 24, Issue:8

    Topics: Adult; Antiprotozoal Agents; Artemisinins; Atovaquone; Azithromycin; Babesia microti; Babesiosis; Diagnostic Errors; Drug Combinations; Equatorial Guinea; Female; Humans; Malaria; Primaquine; Proguanil; Spain; Travel

2018
High-dose ivermectin in malaria and other parasitic diseases: a new step in the development of a neglected drug.
    Parasite (Paris, France), 2018, Volume: 25

    Topics: Administration, Oral; Adult; Animals; Artemisinins; Double-Blind Method; Ivermectin; Kenya; Malaria; Parasitic Diseases; Quinolines; Scabies

2018
Integrated point-of-care testing (POCT) of HIV, syphilis, malaria and anaemia in antenatal clinics in western Kenya: A longitudinal implementation study.
    PloS one, 2018, Volume: 13, Issue:7

    Topics: Adult; Anemia; Anti-Bacterial Agents; Anti-HIV Agents; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Dietary Supplements; Erythromycin; Female; Folic Acid; Guideline Adherence; Health Personnel; HIV Infections; Humans; Iron, Dietary; Kenya; Laboratory Proficiency Testing; Longitudinal Studies; Malaria; Penicillins; Point-of-Care Testing; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Infectious; Prenatal Care; Quinine; Quinolines; Syphilis; Trimethoprim, Sulfamethoxazole Drug Combination

2018
[Diagnosis and Treatment of the First Imported Case of Plasmodium knowlesi Infection in China].
    Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases, 2016, Volume: 34, Issue:6

    Topics: Animals; Antimalarials; Artemisinins; China; Chloroquine; Erythrocytes; Hemeproteins; Humans; Malaria; Microscopy; Plasmodium knowlesi; Polymerase Chain Reaction; Primaquine; Quinolines; Trophozoites

2016
Electrocardiographic Safety of Repeated Monthly Dihydroartemisinin-Piperaquine as a Candidate for Mass Drug Administration.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:12

    Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; Child, Preschool; Drug Administration Schedule; Drug Combinations; Electrocardiography; Female; Healthy Volunteers; Humans; Long QT Syndrome; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mass Drug Administration; Middle Aged; Papua New Guinea; Patient Safety; Prospective Studies; Quinolines

2018
Mass Drug Administration to Control and Eliminate Malaria in Africa: How Do We Best Utilize the Tools at Hand?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 07-02, Volume: 69, Issue:2

    Topics: Africa; Artemisinins; Gambia; Humans; Malaria; Mass Drug Administration; Prospective Studies; Quinolines

2019
Mass Drug Administration With Dihydroartemisinin-piperaquine and Malaria Transmission Dynamics in The Gambia: A Prospective Cohort Study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 07-02, Volume: 69, Issue:2

    Topics: Adolescent; Adult; Aged; Antimalarials; Artemisinins; Child; Child, Preschool; Disease Transmission, Infectious; Female; Gambia; Health Services Research; Humans; Incidence; Infant; Malaria; Male; Mass Drug Administration; Middle Aged; Prevalence; Prospective Studies; Quinolines; Risk Assessment; Young Adult

2019
Development Insights of Surface Modified Lipid Nanoemulsions of Dihydroartemisinin for Malaria Chemotherapy: Characterization, and in vivo Antimalarial Evaluation.
    Recent patents on biotechnology, 2019, Volume: 13, Issue:2

    Topics: Animals; Antimalarials; Artemisinins; Biological Availability; Castor Oil; Coconut Oil; Drug Delivery Systems; Emulsions; Erythrocytes; Hydrogen-Ion Concentration; Malaria; Mice; Nanostructures; Palm Oil; Parasitemia; Patents as Topic; Plasmodium berghei; Polyethylene Glycols; Solubility; Soybean Oil; Static Electricity

2019
Case Report: Birth Outcome and Neurodevelopment in Placental Malaria Discordant Twins.
    The American journal of tropical medicine and hygiene, 2019, Volume: 100, Issue:3

    Topics: Antimalarials; Artemisinins; Developmental Disabilities; Diseases in Twins; Female; Humans; Infant; Infant, Newborn; Malaria; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Premature Birth; Quinolines

2019
Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method.
    Scientific reports, 2019, 01-29, Volume: 9, Issue:1

    Topics: Adolescent; Amodiaquine; Antimalarials; Arrhythmias, Cardiac; Artemether; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Drug Combinations; Ethanolamines; Female; Fluorenes; Heart Rate; Humans; Long QT Syndrome; Malaria; Malaria, Falciparum; Male; Quinolines; Young Adult

2019
Beyond birthweight: benefits and risks of preventing malaria in pregnancy.
    Lancet (London, England), 2019, 04-06, Volume: 393, Issue:10179

    Topics: Artemisinins; Double-Blind Method; Drug Combinations; Female; Humans; Malaria; Pregnancy; Pyrimethamine; Quinolines; Risk Assessment; Sulfadoxine

2019
Clinical impact of the two ART resistance markers, K13 gene mutations and DPC3 in Vietnam.
    PloS one, 2019, Volume: 14, Issue:4

    Topics: Adolescent; Adult; Antimalarials; Artemisinins; Aspartic Acid Endopeptidases; Child; Child, Preschool; Drug Resistance; Female; Humans; Malaria; Male; Mutation; Plasmodium falciparum; Protozoan Proteins; Quinolines; Vietnam; Young Adult

2019
Plasmodium ovale Infection After One Year Mefloquine Prophylaxis in A Young Indonesian Soldier: A Case Report.
    Acta medica Indonesiana, 2019, Volume: 51, Issue:1

    Topics: Antimalarials; Artemisinins; Chemoprevention; Congo; Drug Therapy, Combination; Humans; Indonesia; Malaria; Male; Mefloquine; Military Personnel; Plasmodium ovale; Primaquine; Young Adult

2019
[Descriptive study of malaria cases in the paediatric population in a reference hospital in Valencia, Spain, between 1993 and 2015].
    Anales de pediatria, 2020, Volume: 92, Issue:1

    Topics: Adolescent; Age Distribution; Antimalarials; Artemisinins; Artesunate; Atovaquone; Child; Child, Preschool; Drug Combinations; Equatorial Guinea; Female; Hospitals, Community; Humans; Infant; Malaria; Male; Proguanil; Quinine; Quinolines; Retrospective Studies; Sex Distribution; Spain; Symptom Assessment

2020
Dihydroartemisinin regulates the immune system by promotion of CD8
    Science China. Life sciences, 2020, Volume: 63, Issue:5

    Topics: Animals; Antimalarials; Artemisinins; B-Lymphocytes; CD8-Positive T-Lymphocytes; Cytokines; Drugs, Chinese Herbal; Female; Humans; Immune System; Immunomodulation; Malaria; Mice; Mice, Inbred BALB C; Plasmodium berghei; Spleen; T-Lymphocytes, Regulatory; Toxoplasma

2020
The unanticipated benefits of protecting young children from malaria.
    The Lancet. Infectious diseases, 2019, Volume: 19, Issue:9

    Topics: Artemisinins; Child; Child, Preschool; Double-Blind Method; Humans; Malaria; Quinolines

2019
Devising a strategy for prevention of malaria in pregnant women in the Asia Pacific.
    The Lancet. Infectious diseases, 2019, Volume: 19, Issue:9

    Topics: Artemisinins; Asia; Female; Humans; Indonesia; Malaria; Pregnancy; Quinolines

2019
Differential interactions of the broad spectrum drugs artemisinin, dihydroartemisinin and artesunate with serum albumin.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2013, Aug-15, Volume: 20, Issue:11

    Topics: Animals; Artemisinins; Artesunate; Cattle; Drug Therapy, Combination; Hydrophobic and Hydrophilic Interactions; Malaria; Protein Binding; Serum Albumin

2013
MMV in partnership: the Eurartesim® experience.
    Malaria journal, 2013, Jun-19, Volume: 12

    Topics: Adolescent; Adult; Artemisinins; Cambodia; Child; Child, Preschool; Drug Approval; Drug Combinations; Humans; Infant; Infant, Newborn; International Cooperation; Malaria; Public-Private Sector Partnerships; Quinolines

2013
Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling.
    Malaria journal, 2014, Apr-07, Volume: 13

    Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Child, Preschool; Computer Simulation; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Infant; Malaria; Male; Quinolines; Treatment Outcome; Young Adult

2014
Dihydroartemisinin-piperaquine vs. artemether-lumefantrine for first-line treatment of uncomplicated malaria in African children: a cost-effectiveness analysis.
    PloS one, 2014, Volume: 9, Issue:4

    Topics: Africa; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Cost-Benefit Analysis; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Infant; Infant, Newborn; Malaria; Markov Chains; Outcome Assessment, Health Care; Quinolines

2014
Predicting the parasite killing effect of artemisinin combination therapy in a murine malaria model.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:8

    Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Drug Combinations; Malaria; Mice; Parasite Load; Parasitic Sensitivity Tests; Plasmodium berghei; Quinolines; Recurrence

2014
Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania.
    Malaria journal, 2014, Sep-15, Volume: 13

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Cost-Benefit Analysis; Drug Combinations; Ethanolamines; Female; Fluorenes; Health Care Costs; Hospitals, District; Humans; Infant; Infant, Newborn; Malaria; Male; Models, Statistical; Quinolines; Tanzania; Treatment Outcome

2014
Design, synthesis and evaluation of antimalarial potential of polyphosphazene linked combination therapy of primaquine and dihydroartemisinin.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2015, Jan-23, Volume: 66

    Topics: Animals; Antimalarials; Artemisinins; Humans; Malaria; Mice; Molecular Structure; Nanoparticles; Organophosphorus Compounds; Plasmodium berghei; Polymers; Primaquine

2015
Enantiomerically pure amino-alcohol quinolines: in vitro anti-malarial activity in combination with dihydroartemisinin, cytotoxicity and in vivo efficacy in a Plasmodium berghei mouse model.
    Malaria journal, 2014, Oct-16, Volume: 13

    Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Erythrocytes; Female; Hemolysis; Inhibitory Concentration 50; Malaria; Mice, Inbred BALB C; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Survival Analysis; Treatment Outcome

2014
Population Pharmacokinetics of Piperaquine in Young Ugandan Children Treated With Dihydroartemisinin-Piperaquine for Uncomplicated Malaria.
    Clinical pharmacology and therapeutics, 2015, Volume: 98, Issue:1

    Topics: Antimalarials; Artemisinins; Child, Preschool; Drug Therapy, Combination; Humans; Infant; Malaria; Prospective Studies; Quinolines; Uganda

2015
Synthesis and Evaluation of Substituted Poly(organophosphazenes) as a Novel Nanocarrier System for Combined Antimalarial Therapy of Primaquine and Dihydroartemisinin.
    Pharmaceutical research, 2015, Volume: 32, Issue:8

    Topics: Animals; Antimalarials; Artemisinins; Drug Carriers; Drug Delivery Systems; Electrochemistry; Erythrocytes; Humans; In Vitro Techniques; Malaria; Mice; Nanoparticles; Organophosphorus Compounds; Particle Size; Plasmodium berghei; Polymers; Primaquine; Spectrophotometry, Infrared; Survival Rate

2015
Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania.
    Malaria journal, 2015, Apr-15, Volume: 14

    Topics: Adolescent; Adult; Africa; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Child; Child, Preschool; Cohort Studies; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Health Facilities; Heart Conduction System; Humans; Infant; Infant, Newborn; Longitudinal Studies; Malaria; Male; Middle Aged; Prospective Studies; Quinolines; Young Adult

2015
Treatment policy change to dihydroartemisinin-piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes.
    Malaria journal, 2015, Jul-15, Volume: 14

    Topics: Adolescent; Adult; Antimalarials; Artemisinins; Female; Humans; Indonesia; Infant, Newborn; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Quinolines; Young Adult

2015
Probucol-Induced α-Tocopherol Deficiency Protects Mice against Malaria Infection.
    PloS one, 2015, Volume: 10, Issue:8

    Topics: alpha-Tocopherol; Animals; Antimalarials; Antioxidants; Artemisinins; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Lipid Peroxidation; Malaria; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Parasitemia; Plasmodium berghei; Plasmodium yoelii; Probucol; Survival Analysis

2015
Budget Impact Analysis of Using Dihydroartemisinin-Piperaquine to Treat Uncomplicated Malaria in Children in Tanzania.
    PharmacoEconomics, 2016, Volume: 34, Issue:3

    Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child, Preschool; Cost-Benefit Analysis; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Health Care Costs; Humans; Infant; Malaria; Markov Chains; Models, Economic; Quinolines; Tanzania

2016
Development, characterization and antimalarial efficacy of dihydroartemisinin loaded solid lipid nanoparticles.
    Nanomedicine : nanotechnology, biology, and medicine, 2016, Volume: 12, Issue:3

    Topics: Antimalarials; Artemisinins; Drug Carriers; Humans; Lipids; Malaria; Nanoparticles; Plasmodium; Plasmodium berghei; Plasmodium falciparum

2016
Treatment outcomes in a safety observational study of dihydroartemisinin/piperaquine (Eurartesim(®)) in the treatment of uncomplicated malaria at public health facilities in four African countries.
    Malaria journal, 2016, Jan-27, Volume: 15

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Burkina Faso; Child; Child, Preschool; Female; Ghana; Health Facilities; Humans; Infant; Longitudinal Studies; Malaria; Male; Middle Aged; Mozambique; Quinolines; Tanzania; Treatment Outcome; Young Adult

2016
Community perceptions of mass screening and treatment for malaria in Siaya County, western Kenya.
    Malaria journal, 2016, Feb-06, Volume: 15

    Topics: Antimalarials; Artemisinins; Female; Health Knowledge, Attitudes, Practice; Humans; Kenya; Malaria; Male; Mass Screening

2016
Factors Associated with Non-Participation and Non-Adherence in Directly Observed Mass Drug Administration for Malaria in The Gambia.
    PloS one, 2016, Volume: 11, Issue:2

    Topics: Adolescent; Adult; Aged; Anthropology; Antimalarials; Artemisinins; Attitude to Health; Child; Child, Preschool; Decision Making; Drug Administration Schedule; Female; Follow-Up Studies; Gambia; Humans; Infant; Infant, Newborn; Malaria; Male; Medication Adherence; Middle Aged; Patient Compliance; Patient Education as Topic; Quinolines; Rural Health Services; Rural Population; Young Adult

2016
UK malaria treatment guidelines 2016.
    The Journal of infection, 2016, Volume: 72, Issue:6

    Topics: Adult; Antimalarials; Artemisinins; Artesunate; Breast Feeding; Child; Child, Preschool; Female; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Plasmodium falciparum; Plasmodium vivax; Pregnancy; Pregnancy Complications, Parasitic; Primaquine; Travel

2016
IR and Vibrational Circular Dichroism Spectroscopy of Matrine- and Artemisinin-Type Herbal Products: Stereochemical Characterization and Solvent Effects.
    Journal of natural products, 2016, Apr-22, Volume: 79, Issue:4

    Topics: Alkaloids; Artemisinins; Circular Dichroism; Drugs, Chinese Herbal; Hydrogen Bonding; Malaria; Matrines; Molecular Structure; Quinolizines; Sophora

2016
Probucol dramatically enhances dihydroartemisinin effect in murine malaria.
    Malaria journal, 2016, 09-15, Volume: 15

    Topics: Animals; Antimalarials; Artemisinins; Chemoprevention; Disease Models, Animal; Malaria; Male; Mice, Inbred C57BL; Plasmodium yoelii; Probucol; Treatment Outcome

2016
The acceptability of mass administrations of anti-malarial drugs as part of targeted malaria elimination in villages along the Thai-Myanmar border.
    Malaria journal, 2016, 09-27, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antimalarials; Artemisinins; Child; Child, Preschool; Disease Eradication; Disease Transmission, Infectious; Female; Humans; Infant; Malaria; Male; Middle Aged; Myanmar; Patient Acceptance of Health Care; Pregnancy; Primaquine; Quinolines; Surveys and Questionnaires; Thailand; Young Adult

2016
Multi-Country Evaluation of Safety of Dihydroartemisinin/Piperaquine Post-Licensure in African Public Hospitals with Electrocardiograms.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Adolescent; Adult; Antimalarials; Artemisinins; Black People; Blood Cell Count; Blood Chemical Analysis; Burkina Faso; Child; Child, Preschool; Data Interpretation, Statistical; Electrocardiography; Female; Ghana; Heart; Hospitals, Public; Humans; Malaria; Male; Mozambique; Quinolines; Tanzania; Ventricular Dysfunction; Young Adult

2016
Antimalarial therapies in children from Papua New Guinea.
    The New England journal of medicine, 2009, Mar-19, Volume: 360, Issue:12

    Topics: Antimalarials; Artemether; Artemisinins; Biological Availability; Drug Therapy, Combination; Ethanolamines; Fats; Fluorenes; Humans; Lumefantrine; Malaria; Quinolines; Treatment Failure

2009
Plasmodium berghei ANKA: selection of resistance to piperaquine and lumefantrine in a mouse model.
    Experimental parasitology, 2009, Volume: 122, Issue:3

    Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Chloroquine; Disease Models, Animal; Drug Resistance; Ethanolamines; Female; Fluorenes; Lumefantrine; Malaria; Male; Mice; Parasitemia; Plasmodium berghei; Quinolines; Serial Passage

2009
Development and validation of a high-performance liquid chromatography/tandem mass spectrometry method for the determination of artemether and its active metabolite dihydroartemisinin in human plasma.
    Journal of pharmaceutical and biomedical analysis, 2009, Dec-05, Volume: 50, Issue:5

    Topics: Antimalarials; Artemether; Artemisinins; Calibration; Chromatography, High Pressure Liquid; Formates; HIV Infections; Humans; Malaria; Models, Chemical; Quality Control; Reproducibility of Results; Solid Phase Extraction; Tandem Mass Spectrometry; Time Factors

2009
The pharmaceutical death-ride of dihydroartemisinin.
    Malaria journal, 2010, Jul-22, Volume: 9

    Topics: Antimalarials; Artemisinins; Drug Stability; Humans; Malaria; Pharmaceutical Preparations; Pharmacopoeias as Topic; Public-Private Sector Partnerships; Reference Standards; World Health Organization

2010
A liquid-liquid LC/MS/MS assay for the determination of artemether and DHA in malaria patient samples.
    Journal of pharmaceutical and biomedical analysis, 2011, May-15, Volume: 55, Issue:2

    Topics: Antimalarials; Artemisinins; Calibration; Humans; Malaria; Reference Standards; Tandem Mass Spectrometry

2011
Pharmacokinetics, pharmacodynamics, and allometric scaling of chloroquine in a murine malaria model.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:8

    Topics: Animals; Antimalarials; Artemisinins; Chloroquine; Chromatography, High Pressure Liquid; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Malaria; Male; Mice; Mice, Inbred BALB C; Parasitemia; Plasmodium berghei

2011
Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue.
    Proceedings of the National Academy of Sciences of the United States of America, 2011, Nov-22, Volume: 108, Issue:47

    Topics: Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Blotting, Southern; Dose-Response Relationship, Drug; Ethanolamines; Fluorenes; Genetic Vectors; Germ Cells, Plant; Green Fluorescent Proteins; Luciferases; Lumefantrine; Malaria; Methylene Blue; Naphthyridines; Plasmodium falciparum; Quinolines; Sexual Development

2011
Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:4

    Topics: Adolescent; Adult; Antimalarials; Area Under Curve; Artemisinins; Body Weight; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Malaria; Middle Aged; Myanmar; Nonlinear Dynamics; Population; Predictive Value of Tests; Pregnancy; Pregnancy Complications, Parasitic; Quinolines; Software; Tandem Mass Spectrometry; Thailand; Young Adult

2012
Assessing the consistency assumption by exploring treatment by covariate interactions in mixed treatment comparison meta-analysis: individual patient-level covariates versus aggregate trial-level covariates.
    Statistics in medicine, 2012, Dec-20, Volume: 31, Issue:29

    Topics: Amodiaquine; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Dapsone; Drug Combinations; Ethanolamines; Fluorenes; Humans; Malaria; Meta-Analysis as Topic; Models, Statistical; Outcome Assessment, Health Care; Proguanil; Quinolines; Regression Analysis

2012
Mechanism-based model of parasite growth and dihydroartemisinin pharmacodynamics in murine malaria.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:1

    Topics: Animals; Antimalarials; Artemisinins; Biological Availability; Erythrocytes; Life Cycle Stages; Malaria; Male; Mice; Models, Biological; Parasitemia; Plasmodium berghei

2013
Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2

    Topics: Alleles; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Arylamine N-Acetyltransferase; Base Sequence; Cambodia; Cytochrome P-450 Enzyme System; Drug Combinations; Ethanolamines; Fluorenes; Gene Frequency; Humans; Isoenzymes; Malaria; Mefloquine; Pharmacogenetics; Polymorphism, Single Nucleotide; Quinolines; Sequence Analysis, DNA; Tanzania

2013
Manslaughter by fake artesunate in Asia--will Africa be next?
    PLoS medicine, 2006, Volume: 3, Issue:6

    Topics: Adult; Africa; Antimalarials; Artemisinins; Artesunate; Asia; Drug and Narcotic Control; Drug Contamination; Drug Costs; Drug Packaging; Fraud; Global Health; Humans; Malaria; Male; Sesquiterpenes; Travel

2006
Treatment of malaria in a mouse model by intranasal drug administration.
    International journal for parasitology, 2006, Volume: 36, Issue:14

    Topics: Administration, Intranasal; Animals; Antimalarials; Artemisinins; Disease Models, Animal; Drug Administration Schedule; Female; Malaria; Malaria, Cerebral; Mice; Mice, Inbred ICR; Parasitemia; Plasmodium berghei; Sesquiterpenes; Survival Analysis; Treatment Outcome

2006
Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients.
    PLoS medicine, 2006, Volume: 3, Issue:11

    Topics: Administration, Rectal; Adolescent; Adult; Africa; Aging; Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Child; Child, Preschool; Demography; Female; Humans; Infant; Malaria; Male; Middle Aged; Parasitemia; Salvage Therapy; Sesquiterpenes; Sex Factors; Suppositories; Treatment Outcome

2006
Development of a pharmacodynamic model of murine malaria and antimalarial treatment with dihydroartemisinin.
    International journal for parasitology, 2007, Volume: 37, Issue:14

    Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Dose-Response Relationship, Drug; Erythrocyte Count; Erythrocytes; Malaria; Male; Mice; Mice, Inbred BALB C; Parasitemia; Plasmodium berghei; Sesquiterpenes

2007
CD4 count, viral load and parasite density of HIV positive individuals undergoing malaria treatment with dihydroartemisinin in Benin City, Edo state, Nigeria.
    Journal of vector borne diseases, 2007, Volume: 44, Issue:2

    Topics: Adolescent; Adult; Antimalarials; Artemisinins; CD4 Lymphocyte Count; Child; Child, Preschool; Female; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Malaria; Male; Middle Aged; Nigeria; Prospective Studies; Sesquiterpenes; Urban Health; Viral Load

2007
Plasmodium berghei: parasite clearance after treatment with dihydroartemisinin in an asplenic murine malaria model.
    Experimental parasitology, 2008, Volume: 118, Issue:4

    Topics: Animals; Antimalarials; Artemisinins; Aspartate Aminotransferases; Disease Models, Animal; Erythrocytes; Hemeproteins; Hemoglobins; Leukocyte Count; Liver; Lung; Malaria; Male; Mice; Mice, Inbred BALB C; Parasitemia; Plasmodium berghei; Platelet Count; Sesquiterpenes; Spleen; Splenectomy

2008
Orally active esters of dihydroartemisinin: Synthesis and antimalarial activity against multidrug-resistant Plasmodium yoelii in mice.
    Bioorganic & medicinal chemistry letters, 2008, Feb-15, Volume: 18, Issue:4

    Topics: Adamantane; Administration, Oral; Animals; Antimalarials; Artemisinins; Biphenyl Compounds; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Esters; Malaria; Mice; Models, Molecular; Plasmodium yoelii; Sesquiterpenes; Structure-Activity Relationship

2008
Pharmacokinetic determinants of the window of selection for antimalarial drug resistance.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5

    Topics: Algorithms; Amodiaquine; Animals; Antimalarials; Artemisinins; Chloroquine; Computer Simulation; Drug Resistance; Malaria; Mefloquine; Models, Theoretical; Pyrimethamine; Quinine

2008
Pharmacokinetics of dihydroartemisinin in a murine malaria model.
    The American journal of tropical medicine and hygiene, 2008, Volume: 78, Issue:4

    Topics: Animals; Antimalarials; Artemisinins; Disease Models, Animal; Humans; Malaria; Metabolic Clearance Rate; Mice; Rats; Species Specificity

2008
Antimalarial activity of dihydroartemisinin derivatives by transdermal application.
    The American journal of tropical medicine and hygiene, 1994, Volume: 50, Issue:6

    Topics: Administration, Cutaneous; Animals; Antimalarials; Artemether; Artemisinins; Gels; Malaria; Mice; Plasmodium berghei; Sesquiterpenes; Structure-Activity Relationship

1994
Comparison of in vivo and in vitro antimalarial activity of artemisinin, dihydroartemisinin and sodium artesunate in the Plasmodium berghei-rodent model.
    International journal for parasitology, 1994, Volume: 24, Issue:4

    Topics: Animals; Antimalarials; Artemisinins; Artesunate; Malaria; Mice; Plasmodium berghei; Rats; Rats, Wistar; Sesquiterpenes

1994
Antimalarial activity of new dihydroartemisinin derivatives. 7. 4-(p-substituted phenyl)-4(R or S)-[10(alpha or beta)-dihydroartemisininoxy]butyric acids.
    Journal of medicinal chemistry, 1997, Apr-25, Volume: 40, Issue:9

    Topics: Animals; Antimalarials; Artemisinins; Drug Design; Female; Magnetic Resonance Spectroscopy; Malaria; Mice; Molecular Conformation; Molecular Structure; Parasitemia; Plasmodium berghei; Plasmodium falciparum; Sesquiterpenes; Solubility

1997
Effects of Plasmodium berghei infection on arteether metabolism and disposition.
    Pharmacology, 1997, Volume: 54, Issue:5

    Topics: Animals; Antimalarials; Area Under Curve; Artemisinins; Bile; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Half-Life; Isotope Labeling; Liver; Malaria; Male; Microsomes, Liver; NADPH-Ferrihemoprotein Reductase; Perfusion; Plasmodium berghei; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Tissue Distribution

1997
Synthesis and antimalarial activities of fluoroalkyl derivatives of dihydroartemisinin.
    Journal of medicinal chemistry, 1998, Oct-08, Volume: 41, Issue:21

    Topics: Animals; Antimalarials; Artemisinins; Drug Evaluation, Preclinical; Female; Inhibitory Concentration 50; Malaria; Mice; Plasmodium berghei; Plasmodium falciparum; Sesquiterpenes; Structure-Activity Relationship

1998
Assessment of the effect of malaria infection on hepatic clearance of dihydroartemisinin using rat liver perfusions and microsomes.
    British journal of pharmacology, 1998, Volume: 125, Issue:1

    Topics: Animals; Antimalarials; Artemisinins; Biliary Tract; Glucuronates; Malaria; Male; Metabolic Clearance Rate; Microsomes, Liver; Perfusion; Rats; Rats, Wistar; Sesquiterpenes

1998
Ammunition against malaria.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2001, Sep-04, Volume: 165, Issue:5

    Topics: Antimalarials; Artemether; Artemisinins; Canada; Humans; Malaria; Sesquiterpenes

2001
[Effect of dihydroquinghaosu on the development of Plasmodium yoelii yoelii in Anopheles stephensi].
    Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases, 1998, Volume: 16, Issue:6

    Topics: Animals; Anopheles; Antimalarials; Artemisinins; Malaria; Mice; Plasmodium yoelii; Sesquiterpenes

1998
[Pharmacodynamics of dihydroartemisinine against Plasmodium berghei in mice].
    Yao xue xue bao = Acta pharmaceutica Sinica, 1989, Volume: 24, Issue:7

    Topics: Animals; Antimalarials; Artemisinins; Dose-Response Relationship, Drug; Malaria; Male; Mice; Plasmodium berghei; Sesquiterpenes; Time Factors

1989
The chemotherapy of rodent malaria, XL. The action of artemisinin and related sesquiterpenes.
    Annals of tropical medicine and parasitology, 1986, Volume: 80, Issue:5

    Topics: Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Drug Resistance; Malaria; Male; Mice; Pigments, Biological; Plasmodium berghei; Pyrans; Sesquiterpenes

1986
The chemotherapy of rodent malaria, XXXIX. Ultrastructural changes following treatment with artemisinine of Plasmodium berghei infection in mice, with observations of the localization of [3H]-dihydroartemisinine in P. falciparum in vitro.
    Annals of tropical medicine and parasitology, 1985, Volume: 79, Issue:4

    Topics: Animals; Antimalarials; Artemisinins; Cell Membrane; Endoplasmic Reticulum; Erythrocytes; Malaria; Mice; Microscopy, Electron; Plasmodium berghei; Plasmodium falciparum; Protein Biosynthesis; Ribosomes; Sesquiterpenes; Time Factors

1985